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Abstract 
 
The Cummings School of Veterinary Medicine at Tufts University is the only facility in 
New England with a non-invasive device for diagnosing equine respiratory problems. Their first 
rendition of the device, while functional, was very cumbersome and expensive, leading to a 
partnership with Worcester Polytechnic Institute (WPI) to improve the aspects of this design. 
Following the work of a previous WPI design team and that of Dr. Mazan of the Cummings 
School of Veterinary Medicine, our team refined the display and functionality of LabVIEW code 
for analysis, and developed significant improvements to the mask design in order to house a Rev 
C sensor, which is used for data acquisition. The result of this project is a lightweight, cost 
effective, and reproducible mask design capable of producing consistent and accurate 
measurements of respiratory function.
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Abstract-- The Cummings School of Veterinary 
Medicine at Tufts University is the only facility in 
New England with a non-invasive device for 
diagnosing equine respiratory issues. Following 
the work of the previous WPI design team and 
that of Dr. Mazan of the Cummings School of 
Veterinary Medicine, our team refined the display 
and functionality of the LabVIEW codes used for 
analysis, and made significant improvements to 
the mask design. The result of this project is a 
design capable of producing consistent and 
accurate measurements of respiratory function 
that is both lightweight and cost effective. 
 
I. INTRODUCTION 
 
 80% of stabled horses experience lung 
disorder. Due to their living environment, many 
stabled horses suffer from inflammatory airway 
disease [1]. Roughly 70% of competition horses that 
are kept in athletic facilities experience pulmonary 
disorders [2]. Poor air quality in stables leads to an 
increased risk of these diseases, and is typically caused 
by airborne hay, dirt, excrement, and dust.  
The current method for testing equine lung 
function is an invasive procedure that takes pressure 
measurements using esophageal balloons. 
Additionally bronchoalveolar fluid samples are taken 
for clinical testing for respiratory disorders. These 
testing methods are expensive, and potentially 
traumatizing for the horse. These procedures are often 
ineffective in providing a prompt diagnosis for 
potentially life threatening pulmonary diseases such as 
COPD or Asthma [3]. The Fleisch pneumotachograph 
itself cost $8,000. The remaining system components 
cost approximately $10,000 resulting in a total system 
cost of approximately $18,000 [4]. 
 
 
Fig. 1: Current Fleisch Pneumotachograph  
We continued upon the testing from last 
year’s MQP to create an improved, non-invasive 
diagnostic device that would be a cost effective tool 
for the data collection and data analysis of horse lung 
function testing. The previous year’s device used a hot 
wire anemometer, comparable to the fleisch 
pneumotachograph, but significantly more lightweight 
and inexpensive. Our MQP team validated the sensor 
and developed a mask housing system to be mounted 
on the horse during respiratory testing. Additionally 
we improved upon the existing LabVIEW and excel 
outputs for live data monitoring and data analysis. 
II. DESIGN APPROACH 
 To meet Dr. Mazan’s requirements, the 
design needed to be lightweight, attachable to a 
standard bridle, breathable, moisture absorbent, and 
easily applied and cleaned. In addition to the mask 
design, the LabVIEW code needed to be restructured 
and redesigned for better user interface (UI). The 
labview code needed to be updated to better reflect the 
respiratory patterns of a horse. Preliminary designs 
included a kinetics model on a replica horse and 
Solidworks models designed to fit a standard bridle.  
 We tested several materials for the 
framework of the mask which involved a comparison 
of material properties versus weight and price. The 
internal materials were tested for water absorption, 
breathability, and ability to direct airflow through the 
sensor housing tube. Our LabVIEW code provides a 
simplified monitoring display with minimal user 
inputs. The color scheme and layout of the individual 
graphs were altered for improved visibility and 
comparison. We removed global variables from the 
code, which improved the speed of the code, reduced 
file size, and limits errors when running tests on 
different computers.  
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III. FINAL DESIGN 
 The final design consisted of a frame made of 
3D printed acrylonitrile butadiene styrene (ABS) and 
a neoprene mesh suspended within the frame. Expired 
air is directed through the neoprene mesh into the ABS 
tube on the front of the mask. The air then passes over 
the Rev C sensor which is connected to a computer 
which uses LabVIEW software to run our LabVIEW 
code for data analysis. Figure 2 below illustrates the 
final Solidworks model for the design. 
 
 
Fig. 2: Final Respiratory Mask Design 
 
 The LabVIEW display was updated and 
simplified in design and operation. The display 
presented a simplified grey background with two 
displays for the breathing rate in respect to velocity 
and in relation to volumetric breathing rate. The raw 
data is extracted to a local file on the user’s hard drive, 
and may be reflected for additional display and peak 
ranges through an Excel or Matlab code.  
IV. TESTING 
Various materials were tested with an Instron 
5543 in a 3pt bending testing (ABS mask design) for 
compressive and bending stresses, and tensile testing 
(neoprene mesh). Figure 3 below indicates the Load-
Extension curve of the Neoprene mesh. 
                 
Fig. 3: Tensile Testing Neoprene Fabric 
 
 Additionally, the breathability and water 
resistance of the mesh were tested by using a contact 
angle test and breathability testing. We concluded 
from testing that ABS 3D printed material is the ideal 
material based on weight and cost, and neoprene is the 
ideal material for the internal mesh based on design 
specifications and cost.  
V. FUTURE WORK 
 Future recommendations for the continuation 
of this project include the incorporation of respiratory 
Inductance Plethysmography (RIP) bands to the 
system and LabVIEW code, as well as designing a 
wireless alternative for mobile testing through the use 
of an Arduino, or other device capable of data 
acquisition. We recommend testing this sensor and 
code on live horses to gauge response to the system in 
action.  
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Chapter 1: Introduction 
 
As many as 80% of stabled horses experience lung disorders. Due to the environment in 
which they live, many stabled horses suffer from inflammatory airway disease (Cummings 
Veterinary Medical Center, 2016). Roughly 70% of competition horses that are kept in athletic 
facilities experience pulmonary disorders (Robinson, 2003). Most stables have poor air quality 
due to hay, dirt, excrement, and dust, leading to an increased risk of these diseases. Horses are 
the key component of many well-established industries. Equine industries contribute 
approximately $39 billion to the U.S. economy, and support 1.4 million full-time jobs, 
(American Horse Council, 2017). Maintaining the horse’s health is important to the survival of 
these industries. Because respiratory issues are so prevalent, diagnosis, treatment, and prevention 
are critical. This report focuses on improving the diagnostic device that is used for equine 
respiratory diseases. 
A current method for testing equine lung function is an invasive procedure that takes 
pressure measurements using esophageal balloons; it takes bronchoalveolar fluid samples for 
clinical testing of respiratory disorders. These testing methods are expensive, and potentially 
traumatizing to the horses. These procedures are often do not provide a prompt diagnosis for life 
threatening pulmonary diseases such as Chronic Obstructive Pulmonary Disorder and Asthma 
(Mazan, Personal Communication, 2017). Delayed prognosis and diagnosis of these diseases 
compromise the veterinarian’s ability to prevent permanent damage to the respiratory system 
(Mazan, Personal Communication, October 24, 2017). Two alternatives to this method are a non-
invasive passive airflow device and a forced oscillatory mechanic (FOM) device.  
Dr. Melissa Mazan is a veterinarian from the Cummings School of Veterinary Medicine 
at Tufts University, specializing in the analysis of equine lung function. She utilizes both the 
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passive airflow device and the FOM through a Fleisch pneumotachograph to measure flow rate, 
lung pressure, and lung capacity of horses. The pneumotachograph outputs data through a virtual 
interface, displaying the measured results. Additionally, Respiratory Inductance 
Plethysmography (RIP) bands are strapped on the thoracic region of the horse. These measure 
the change in output volume through the same virtual interface (Mazan, Personal 
Communication, September 9, 2016). From this data, Dr. Mazan interpolates the possible 
respiratory diseases based on the variations in graph slope and distribution. The interface and 
device were developed by Dr. Andrew Hoffman of Tufts University Cummings School of 
Veterinary Medicine, another equine expert. 
The passive device is used frequently in testing and diagnosis due to its simplicity of 
operation and because it is available for use with all race horses, regardless of age or condition. 
The FOM device can only be used on young racehorses and sport horses. Older horses or 
severely affected horses cannot use this device because their breathing rates too closely matches 
the frequency of the sine waves to be distinguishable, (Mazan, Personal Communication, 
October 24, 2017). Although the passive device has proven to be an effective testing mechanism, 
it poses some concerns that need to be addressed. The Fleisch pneumotachograph used for the 
current device is no longer in production, making it difficult to replace. The current device is also 
expensive. The Fleisch pneumotachograph itself cost $8,000 and can only be calibrated to an 
accuracy of ± 3.33%. The remaining system components cost approximately $10,000 resulting in 
a total system cost of approximately $18,000 (Mazan, Personal Communication, September 9, 
2016). The current device is also heavy, approximately 3 lbs., and protrudes from the horse’s 
muzzle by 12 in., which poses the risk of head injuries to the human operators due to a horse’s 
tendency to swing it’s head. The costs, risks, and inconveniences of using the device in the field 
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makes the Fleisch pneumotachograph inaccessible to other veterinarians. Thus, Cummings 
School of Veterinary Medicine at Tufts is the only location in the Northeast that uses the Fleisch 
pneumotachograph (Mazan, Personal Communication, September 9, 2016).    
Last year, a team of WPI students was tasked with creating an improved, non-invasive 
diagnostic device that would be a cost effective solution to the data collection and analysis of 
horse lung function testing. They determined that a hot-wire anemometer would be comparable 
to the current system’s Fleisch pneumotachograph, while being significantly less expensive. 
Additionally, they focused on creating an output display in LabVIEW that would respond to the 
live feed of the system, so that veterinarians can view the abnormalities present in the breathing 
rate and volume. The work of the previous team provided a basis to improve the equine lung 
function test, however before this is fully investigated and utilized in the field, a number of 
primary objectives need to be met to improve functionality and safety of the device.  
 Our sponsor, Dr. Mazan, provided us with a client statement in order to improve the 
design of the sensor housing and mask. The limitation of the current design is that it is large and 
cumbersome, and is a danger to the people operating the device. Dr. Mazan herself was 
hospitalized due to the current device. Additionally to the safety concern, the device is heavy, 
weighing approximately 3 lbs. This requires an assistant to hold the device upright while the 
horse is undergoing testing because the horse is not able to support the weight of the device. This 
is a significant limitation as normal activities cannot be measured such as running and jumping 
over obstacles. Beyond the scope of the physical limitations of the current design, financially, the 
current design is not feasible for most veterinarians interested in testing equine lung function. 
The current model costs upwards of $18,000, and is no longer in production, making diagnosis of 
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equine lung function, and the repair of the system costly (Mazan, Personal Communication, 
September 9, 2016). 
Our team evaluated the current mask design, and produced a lightweight, form-fitting 
mask that adjusts over a standard bridle and houses a hot-wire anemometer. Dr. Mazan indicated 
sanitation as a major consideration in the design, as this system is used interchangeably with 
each horse. Another priority is to design the mask to be easily cleaned.    
 We prototyped potential mask designs based on cost effectiveness, strength, and weight. 
Through our literature review, we concluded that the anemometer must be exposed to direct flow 
from the nose of the horse. With this in mind, we created a wireframe support structure leading 
from the clips on the side of the bridle. The design is sealed to the horses face with a rubber 
sheath, fitting over the horse’s nose. The wireframe is velcroed into place, and protrudes 1 inch 
from the horse’s nose. The air is directed downwards through a hole in the inferior segment of 
the mask, while providing a spit release so no moisture accumulates.  
Our device was tested through the use of a wind tunnel, which simulated the speed and 
volume of a horse. We calculated the weight of our designed unit and found that it is 0.91 lbs. 
From this, we determined that our system is a significant improvement on the current system, 
given the reduction in weight, reduction in price, and similar effectiveness when compared to the 
old system.  
This report illustrates our understanding of the design considerations necessary to 
develop an improved equine lung function testing apparatus, and the limitations of current 
designs on the market. 
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Chapter 2: Literature Review 
 
2.1 Equine respiratory system 
The respiratory system is the pathway to exchange oxygen and carbon dioxide. Air 
travels into the horse’s pulmonary system through the upper respiratory tract (URT) and then the 
lower respiratory tract (LRT) (Davis, 2013; Crabbe, 2007). The URT consists of nostrils, nasal 
passages, pharynx, larynx, and the trachea. The LRT consists of the structures in the lung 
including the bronchi, bronchioles, and alveoli (Davis, 2013). 
In the URT, Cartilage rings inside the nostrils can expand to allow increased airflow, 
which is necessary during exercise (Crabbe, 2007). Air continues through the nostrils and nasal 
passages to the pharynx. The pharynx in a horse has two purposes: facilitate airflow to the larynx 
and transport food to the esophagus from the oral cavity (Davis, 2013; Crabbe, 2007). The soft 
palate separates the oral cavity from the pharynx and only allows airflow through the oral cavity 
when the horse is swallowing (Davis, 2013). The epiglottis also assists in keeping food from 
entering the larynx by separating the trachea and esophagus. When air is flowing into the trachea 
the epiglottis blocks the esophagus by lying flat over the esophagus. When the horse is 
swallowing food, the epiglottis blocks the trachea using the same mechanism (Crabbe, 2007). 
Together the soft palate and epiglottis cause horses to be obligatory nose breathers (Davis, 2013; 
Crabbe, 2007). Figure 2.1 shows airflow as the horse inhales, and displays that the horse is an 
obligatory nose breather because the soft palate location does not allow airflow from the mouth 
to the trachea. 
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Figure 1: Airflow into the horse during inspiration. 
 
As air flows through the trachea and enters the LRT through two bronchi (Davis, 2013; 
The British Horse Society, 2011; Crabbe, 2007). One bronchi branch enters the left lung and the 
other to the right lung. The two bronchi branches proceed to branch further forming into 
bronchioles. At the end of the bronchioles are alveoli, also known as alveolar sacs. In the alveoli, 
oxygen in the air diffuses into the pulmonary capillary circulation to be absorbed by the blood 
and carbon dioxide diffuses into the alveoli (Davis, 2013; The British Horse Society, 2011). This 
process of diffusing oxygen from the air into the blood is called oxygen exchange (Raven & 
Rashmir-Raven, 1996). The carbon dioxide in the alveoli is then exhaled out of the horse, which 
concludes one breath of airflow through the respiratory system (Davis, 2013). 
 
2.2   Respiratory disorders of horses 
Equine respiratory disorders are quite common. Horses can have a number of disorders 
including recurrent airway obstruction, inflammatory airway disease, and other less common 
disorders. Diagnosing the disorders is problematic as differentiating between the many disorders 
is difficult. Unlike with other animals, the symptoms and results of specific tests do not lead to 
one specific diagnosis. Veterinarians have to stay up to date with frequently changing disorder 
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definitions. A correct diagnosis is also difficult because the disorders are often subclinical, so the 
horse may suffer for extended periods of time before a test is performed or a clinical level 
disorder is detected. Wrong diagnoses can be serious because different treatment methods are 
used for each disorder. Incorrect treatment can cause the disorder to worsen. 
 
2.3   Recurrent airway obstruction (RAO) 
Recurrent airway obstruction (RAO) is commonly seen in older horses that are 
experiencing airway obstruction, inflammation, mucus accumulation, or tissue remodeling. RAO 
is the most commonly diagnosed lower airway disease in horses and is very similar to non-
eosinophilic asthma in humans. RAO is believed to be caused primarily by an allergic reaction to 
inhaled molds. 
Many horses live in closed barns where hay is stored. It is common for hay to develop a 
dusty and moldy living environment, which aggravates the respiratory system of horses, causing 
diseases such as RAO. The most common sign of RAO is frequent labored breathing. 
Fortunately, RAO is reversible if correctly diagnosed early on. The most common steps that can 
be taken to reverse the effects of RAO are to reduce the dust in the horses living environment 
and administer a bronchodilator (Kutasi, Balogh, Lajos, Nagy, & Szenci, 2011). 
 
2.4   Inflammatory airway disease (IAD) 
RAO and inflammatory airway disease (IAD) are similar, but they can be differentiated at 
the clinical level. IAD is a non-septic inflammation of the lower airways that is common in 
young sport horses and can be caused by many different factors. These factors can include dust 
and mold spores in their living environment, immunological factors, and infectious agents. If 
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IAD is untreated it can progress into RAO. IAD is commonly untreated because most cases have 
subclinical symptoms that go unrecognized by the owner. 
 2.5    Other disorders 
Pulmonary disorders caused by infections can affect horses, however they are less 
common than RAO and IAD. These disorders can be caused by bacterial, viral, fungal, or 
parasitic agents. Infections are typically seen in older horses that have been subjected to 
increased stresses including long distance travel or strenuous exercise (Kutasi, et al., 2011). 
Pulmonary hemorrhaging is the second most prevalent disorder found in young 
racehorses after IAD. Exercise-induced pulmonary hemorrhaging is common in racehorses and 
sport horses, but most commonly in racehorses who have to over exert themselves for short 
periods of time. This most commonly occurs because of inflammation in the upper and lower 
airways that applies excessive stress to the pulmonary circulatory system, (Kutasi, et al., 2011). 
These hemorrhages should be treated as soon as they are detected, however symptoms are often 
minimal so frequently they go undetected. Lastly, while rare, horses can be diagnosed with 
granulomatous, neoplastic disease, or pneumonia (Kutasi, et al., 2011). 
2.6 Diagnosing disorders 
Veterinarians commonly encounter horses with lung function disorders. One of the first 
tasks a veterinarian will complete is checking the contagious nature of the disorder. Horses often 
live in close proximity of other animals, and risk of spreading contagious infections should be 
minimized. The horse’s age, breed, sex, origin, environment, herd or group history, vaccination, 
deworming, and medical history are all required information the veterinarian will ask the client 
(Kutasi et al., 2011). These questions provide insight into the potential causes behind any 
disorders. For example, a horse living in a barn that stores damp hay is an environment that 
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makes horses more susceptible to respiratory infections (Robinson, 2003). The veterinarian will 
also inquire about any symptoms the horse might be displaying. These include: 
 Cough 
 Nasal and or ocular discharge 
 Exercise intolerance 
 Respiratory distress 
 Sneezing 
 Abnormal respiratory noise 
 Elevated breathing rate 
 Abnormal respiration pattern 
 Depression 
 Fever 
 Anorexia 
 
Before any further testing, the condition of the horse will be examined. This includes 
noting the manner of movement, demeanor, body condition, abdominal movement, presence of 
nostril flare, and respiratory rate. The horse will be further examined, looking at mucus 
membranes, any swelling, abnormal nasal discharge, signs of pain, or swollen glands. A 
stethoscope is used to see if any abnormal breathing sounds can be heard. A test known as the 
brown bag exam is used to determine if the lower airways are obstructed. During the bag 
rebreathing exam, wheezes and crackles could be a sign of an obstruction and tracheal rattling 
could be mucus accumulation in the lower airways, (M. Mazan, Personal Communication, 
September 30, 2016). 
Coughing while the bag is on or prolonged recovery time after the bag is removed are 
signs of a respiratory disorder (Katusi et al, 2011). For IAD, oftentimes the blood chemistry is 
completely normal, but accumulation of bacteria in the trachea could be a sign of the disease 
(Robinson, 2003). After understanding the horse’s past, further testing can be completed to 
determine if a lung function disorder is present. 
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2.7    Pulmonary function tests 
Pulmonary function tests (PFTs), or lung function tests, are tests employed to determine 
the quality of the respiratory system’s performance (U.S. National Library of Medicine, 2015). 
Most tests focus on measuring lung function through defining lung capacity, respiratory rate, and 
proficiency of oxygen exchange to the blood (U.S. National Library of Medicine, 2015). 
Often the first step for diagnosis using PFTs is a physical examination with a stethoscope 
(Myers & Bass, 2010). Doctors listen with a stethoscope for any abnormal respiratory sounds 
(Myers & Bass, 2010; Yu, Tsai, Huang, & Lin, 2013). Doctors generally listen for wheezing, 
commonly associated with asthma, difficulty breathing, restricted airways, or other obstructions 
passing through the respiratory system.(Myers & Bass, 2010; Yu, et al., 2013). When wheezing 
becomes severe enough, it is heard without a stethoscope (Myers & Bass, 2010). Hearing these 
obstructions through a stethoscope is not enough to provide a diagnosis of asthma, instead other 
PFTs must be conducted to fully determine the presence of asthma or other pulmonary disorders. 
Spirometry is a common PFT to determine the presence of different lung diseases. It 
measures the amount of air a person exhales and the speed of exhalation (U.S. National Library 
of Medicine, 2015). This test is dependent on compliant breathing, a person’s ability to follow 
directions to breath at a specific time with a certain amount of effort (U.S. National Library of 
Medicine, 2015). Often spirometry is conducted with a person postured in a sitting position with 
a mouthpiece to breathe in (U.S. National Library of Medicine, 2015). 
Methacholine tests use spirometry to determine lung function while breathing in specific 
agents such as methacholine or histamine (American Thoracic Society, 2009). When people with 
asthma breathe in methacholine, their airways tighten, further restricting breathing, (American 
Thoracic Society, 2009). Since patients without asthma will not have their airways tightened with 
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exposure to those specific agents, this method is extremely useful in diagnosis (Scope, 
Contraindications, & Training, 1999). 
Spirometry and spirometry with methacholine challenge tests require compliant 
breathing. Human infants and animals are unable to follow directions to provide maximum 
exhalation (Rozanski & Hoffman, 1999). Tidal breathing flow-volume loops, a pulmonary 
function test that does not require complaint breathing, was initially designed for human infants, 
but was determined useful for pulmonary disorders in animals such as dogs and cats (Rozanski & 
Hoffman, 1999). As the infant or animal breathes into this device, it measures respiratory rates 
through a pneumotachograph with a pressure transducer (Rozanski & Hoffman, 1999). This 
process takes several minutes because the flow-volume loops require time to appear consistent in 
shape and there needs to be breathing patterns without crying, purring, or panting (Rozanski & 
Hoffman, 1999). 
As described in the previous section, other tests and questionnaires are completed before 
a non-compliant animal is tested for a lung function disorder. Lung function testing is only 
performed as a last resort if no other testing methods provide a clear diagnosis,  (PetWave, 
2015). Once all of these methods are exhausted and a diagnosis is not identified, lung function 
testing is considered. Typically, lung function testing is invasive, expensive, and has many 
limitations as described in section 2.5. 
2.8    Equine pulmonary function tests 
There are many techniques for testing lung function in horses to include imaging, taking 
samples, laboratory diagnostic techniques, and newer methods that focus on the actual breathing 
patterns of the horse. Each one of these techniques has different advantages and disadvantages, 
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so they are used in different situations, which is investigated and discussed in the following 
sections. 
2.9    Imaging 
Imaging is typically used for horses that have clear symptoms of a pulmonary disorder. 
Most of these techniques are invasive, but they can provide a proper diagnosis with high levels 
of accuracy and precision. The key imaging techniques that are used currently include 
endoscopy, radiography, and thoracic ultrasonography. 
Respiratory tract endoscopy is commonly used for diagnosing horses who are 
experiencing abnormal nasal discharge, coughs, or poor performance during exercise. Endoscopy 
allows for imaging of the upper respiratory tract and the proximal lower respiratory tract. This 
procedure is performed by inserting an endoscope through the nares (nostrils) of the horse into 
the upper respiratory system (Pusterla, Watson, & Wilson, 2006). RT Endoscopy provides an 
accurate diagnosis and it does not always require sedation, but it is an invasive procedure, 
(Kutasi, et al., 2011). 
Radiography is another common imaging method used for diagnosing lung function 
disorders in horses. Radiography is key to locating the cause of a disease by identifying fluid-air 
lines in the lung. This equipment is advantageous because it can image small areas of the lung 
including the paranasal sinuses, the guttural pouches, and the retropharyngeal area that the other 
imaging technologies cannot access. A major disadvantage with radiography is that it has very 
limited usage due to the fact that it is not readily available (Pusterla, et al., 2006). 
When analyzing a horse using radiography veterinarians are looking for one of four 
common patterns, which include the alveolar pattern, the interstitial pattern, the reticular pattern, 
and the bronchial pattern. These are typical patterns to look for in any species when using 
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radiography, but unlike in other species, horses do not have one diagnosis that matches with each 
distinct pattern. For horses, each pattern represents a range of possible diagnoses that often 
overlap with each other. The major limitation of diagnosing by fluid-air line patterns is that the 
most common pattern, the interstitial pattern, does not clearly define any specific disorders. 
Table 2.1 illustrates the overlapping definitions that veterinarians need to be aware of when 
caring for a horse with a pulmonary disease. 
Pattern Disorders 
Alveolar Pulmonary edema, hemorrhage, lung consolidation, or neoplastic 
infiltration 
Interstitial Variety of diseases, has no clear definition of diagnosed disorders 
Reticular Most common with viral, bacterial, and fungal infections 
Also, present in horses with pulmonary edema, interstitial 
pneumonia, and pulmonary fibrosis 
Bronchial Bronchitis or bronchiolitis 
Table 1: Air-fluid patterns common in horses and what disorders they represent. 
Thoracic ultrasonography is more readily available than radiography, so it is used more 
often especially if pleural effusion, pulmonary consolidation, pulmonary or mediastinal 
abscesses, tumors or granulomas are being detected. The main limitations of ultrasonography are 
the lengthy process to prepare the horse and the ease of doing something improperly. These 
limitations combined can lead to an inefficient test. Ultrasonography also has a very limited 
number of disorders that it can diagnosis (Pusterla, et al., 2006). 
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2.10   Sampling 
Multiple sampling methods are used to diagnose equine respiratory disorders including 
tracheal wash, bronchoalveolar lavage (BAL) fluid cytology and culture, thoracentesis, and 
percutaneous lung biopsy. Similar to imaging, each one of these techniques is invasive. 
Tracheal washes detect different disorders by collecting a sample from the distal trachea. 
This is done using an endoscope or a percutaneous tracheal wash. The percutaneous tracheal 
wash requires surgical skin preparation and has a risk of infection at the insertion site, but if the 
sample needs to be cultivated for diagnosis, this method is required. 
Endoscopy can acquire the sample, but it will be contaminated by the nasopharyngeal 
bacteria, so it can only be used for cytological examination. Acute inflammation, bacterial 
pneumonia, credence, fungal infections, viral infection, and non-septic inflammation can be 
detected with this method of sampling. Table 2.2 below shows what cells are present during the 
different disorders that can be diagnosed (Pusterla et al., 2006). 
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Disorder Cells Present 
Acute inflammation Neutrophils 
Bacterial pneumonia Neutrophils showing signs of degeneration 
Credence Intracellular bacteria 
Fungal infection 
 
Neutrophilic infiltration, large number of eosinophils and 
macrophages 
Viral Infection Increase in lymphocytes and epithelial cell injury 
Non-septic 
inflammation 
Non-degenerative inflammatory cells with no evidence of etiologic 
agents 
Table 2: Cells present in disorders. 
BAL is the most common sampling method used by veterinarians testing for diffuse 
inflammatory disorders in horses. An endoscope is used to retrieve a sample of the fluid lining in 
the distal airways in the alveoli. This sample is then used in cytological examination or 
quantitative culture techniques. Quantitative culture techniques must be used so that 
contamination due to the nasopharyngeal bacteria can be ignored. The BAL sample cell 
distribution is compared to a normal cell distribution to determine the disorder (Pusterla et al., 
2006). Veterinarians can use a similar method to diagnose the disease using the cell types listed 
in Table 2.2. 
Thoracentesis can be completed quickly and easily with little equipment, so it is the 
preferred method for many veterinarians. Once the sample is collected both culture and cytology 
analyses can be conducted, along with the analysis of the odor, color, and consistency of the 
sample. A normal sample should be odorless, transparent, and slightly yellow, so if the sample 
taken does not appear normal, then there is an abnormal cell present meaning the culture and 
cytology examinations should be conducted. This sampling method is used to easily and quickly 
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diagnose disorders such as; pulmonary abscesses, pneumonia, chronic obstructive lung disease, 
pulmonary granulomata, equine infectious anemia, systemic mycosis, traumatic penetration of 
the thorax, and primary and secondary thoracic neoplasms. There are a few risks because it is an 
invasive procedure, with the exceptions being the chance of pneumothorax, cardiac puncture, 
intercostal artery or vein laceration, and patient collapse due to rapid removal of large amounts 
of fluid. Although these results are very uncommon, they can occur, so this method is typically 
only used if other diagnostic methods do not work (Pusterla et al., 2006). 
The last sampling technique used is the percutaneous lung biopsy, which is extremely 
invasive and has many complications. These complications include epistaxis, pulmonary 
hemorrhage, tachypnea, respiratory distress, pneumothorax, collapse, and potentially death. 
Since there is such a high risk for this procedure, it is typically a last resort and is only used 
when all less invasive diagnostic methods have failed to provide an accurate diagnosis. This 
procedure can be conducted in non-sedated, standing horses, but is commonly done on a 
restrained horse in the stock. To try to reduce the risk of the complications, ultrasonography 
evaluations are conducted before the procedure to map the major organs to avoid puncture while 
accessing the desired location. The percutaneous lung biopsy is typically used to diagnose 
diffuse lung disease or undetermined etiology (Pusterla et al., 2006). 
Sampling techniques allow for both sensitive and accurate results if contamination is 
taken into account, but each technique is invasive and has a risk of serious complications. 
Therefore, veterinarians are moving towards less invasive methods that are just as sensitive and 
accurate. They do have special laboratory diagnostic techniques that they can use, but they are 
only used for very specific disorders, which are discussed in the following section. 
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2.11    Special laboratory diagnostics 
Special laboratory diagnostics may be used when trying to diagnose very specific 
disorders or when imaging and sampling do not provide a clear diagnosis. These laboratory 
techniques include hematology, immunodiagnostic testing, and molecular diagnostics. 
Hematology is a very sensitive and time dependent method of determining if the 
pulmonary disorder is infectious or noninfectious based on the increases of cell types over time. 
The limitation of this method are that the changes in cell type is miniscule, making effective 
analysis difficult unless it is a chronic disorder. This method can be used to detect inflammation 
quite accurately because inflammation is dependent on plasma concentration (the higher the 
plasma concentration, the higher the levels of inflammation), which is easier to quantify than the 
small changes in the different cell types.  Hematology is commonly only used to determine if 
inflammation is present, but if records are kept well and the test is conducted cautiously, 
information on the infectious versus noninfectious nature of the disorder can be determined 
(Pusterla et al., 2006). 
Immunodiagnostic testing is a serologic test that is conducted to determine the presence 
of specific antibodies. The antibodies are detected by using enzyme-linked immunosorbent assay 
(ELISA), radioimmunoassay, or immunofluorescence methods. This type of testing can be used 
to determine the disease progression, detect if the patient is a carrier of a disease, and to 
distinguish between vaccination, exposure, and disease. A limitation of this test is the 
veterinarian needs to have a solid understanding of what the results of each test mean. A positive 
test may mean an active disease, but it often does not. Instead, the positive results may indicate 
the carrying ability of the subject for the specified antibodies. However, a negative result does 
not mean that the horse does not have the disease. Veterinarians need a strong understanding of 
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the sensitivity and specificity of the test to interpret results correctly. Another limitation of this 
method is the age of the horse can affect the results. Older horses may exhibit higher levels of 
antibodies, providing false-positive results. Since the test does not give clear results, it is difficult 
to use for accurate diagnoses and is not reliably repeatable (Pusterla et al., 2006). 
Lastly, molecular diagnostics can be used to diagnose infections caused by pathogens that 
are difficult to cultivate. For this method, Polymerase Chain Reaction (PCR) is used to amplify 
the sample and ELISA is used to determine if antigens are present. This method is still in the 
development phase, but its applications have been increasing. For it to be widely used the ease of 
use, safety, cost efficiency, sensitivity, reproducibility, and automation need to be improved. The 
speed and reliability of molecular diagnostics are advantageous to other diagnostic methods, but 
it is paired with the disadvantage of producing false positives due to PCR contamination. These 
special laboratory diagnostic techniques are used primarily for infectious disease diagnostics. 
Infectious disease makes up a minimal portion of all pulmonary disorders in horses, but if these 
methods are made easier and more reliable, they might be applied more frequently in the future 
to test for infectious diseases before testing for other disorders. 
2.12   Additional methods 
Veterinarians have begun to use less invasive methods for diagnosing equine lung 
function disorders, such as conventional mechanics, flowmetric plethysmography, histamine 
challenge, bronchodilator challenge, and forced oscillatory mechanics. 
Of the invasive methods, the conventional mechanics method is considered the gold 
standard for lung function testing, but it is invasive. A balloon-tipped esophageal catheter is 
placed in the thoracic esophagus to measure the pleural pressure. This pleural pressure is 
measured at the same time as the flow at the nostrils. The flow at the nostrils is measured with a 
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pneumotachograph. Software is used to find the resistance, dynamic compliance, and end 
expiratory work from the measured airflow, pressure, and respiratory rate. One limitation of this 
device is the invasiveness causes the horse to swallow frequently, causing pressure readings to 
be inaccurate. It also has low sensitivity, making it difficult to detect small airway obstructions. 
The low sensitivity is due to low resistance in small airways at normal breathing and 
changes in resistance and compliance as frequencies change. This method is applied in severe 
cases, but can be made more sensitive when coupled with a histamine challenge (Mazan, & 
Hoffman, 2003). 
The histamine and bronchodilator challenges are bronchoprovocation methods to detect 
low-grade airway obstruction. Horses suffering from low-grade airway obstruction have airway 
hyperactivity, meaning the airway is more responsive to a mild stimulus than healthy functions 
would be. The causes of this hyperactivity may range from airway thickening caused by 
inflammation, mucus, hyperplasia of the epithelial cells, and high acetylcholine or defective 
neural response. Histamine challenges are conducted more frequently than bronchodilator 
challenges; in this test, forced oscillatory mechanics (FOM) is used to measure the resistive 
friction (RRS). A baseline is set with FOM and histamine is administered in 2 mg/mL doses until 
the RRS increases more than 75%. Table 2.3 displays the level of obstruction based on the 
histamine dosage reactivity occurs at. 
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Histamine dosage where 75% reached Airway Obstruction Classification 
less than 2 mg/mL Severe reactivity, probably has signs of heaves 
2 mg/mL - 4 mg/mL Moderate airway obstruction 
4 mg/mL - 6mg/mL Mild airway obstruction 
6 mg/mL Considered healthy and normal 
Table 3: Airway Reactivity based on Histamine. 
When a horse reacts to low doses of histamine, a bronchodilator challenge is typically 
performed. This measures the obstruction and determines if a bronchodilator treatment is right 
for the horse. Albuterol is the bronchodilator of choice because it has a shorter wait time after 
administering, (15-minute wait time), but Ipratropium bromide (45-minute wait time) may also 
be used if time is not a concern (Mazan, & Hoffman, 2003). 
Cummings School of Veterinary Medicine at Tufts University uses a combination of 
flowmetric plethysmography and a Fleisch Pneumotachograph to quantify obstructions 
experienced by the horse. This method is a sensitive, non-invasive test that provides an accurate 
diagnosis. This method and a similar forced oscillatory mechanics (FOM) method are described 
in significant detail in section 2.6. 
 
2.13 Cummings School Gold Standard 
Cummings School of Veterinary Medicine measures equine lung function utilizing a 
Fleisch pneumotachograph. This is a flow meter relating the velocity of breath from the horse to 
time. Increasing the flow through the pneumotachograph creates a linear relationship when 
calibrating the equipment, and accurately measures the breathing rate of the horse. The 
pneumotachograph is based off of Poiseuille's Law, stating that under capillary conditions in a 
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rigid tube, the flow is proportional to the pressure loss per unit length. This is particularly 
beneficial in ensuring an accurate translation of flow velocity and pressure for diagnostics. (2.2) 
shows a Fleisch pneumotachograph during testing and a schematic of the current device. 
 
 
 
 
Figure 2: A horse being tested with the passive Fleisch pneumotachograph device; Figure 3: A schematic of the 
current device and how it works. 
 
The arrows in Figure 2.2(B) represent the flow of air through the device.  The pressure 
drop is detected and measured through the capillary bed in the Fleisch pneumotachograph. The 
pneumotachograph is calibrated using a 3 liter syringe, forcing a specified quantity of air through 
the system over a specific amount of time. The pressure loss, or difference in pressure between 
two points, creates a curve that represents velocity of the air flowing (Vitalograph, 2016). 
Several capillary tubes direct the airflow to reduce turbulence in the tube, inducing laminar flow. 
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This creates a simplified characteristic equation set based on laminar fluid mechanic properties. 
A transducer is included in the device, which collects a voltage signal from the pressure drop and 
converts it to a signal  displayed using the Open Pleth software, designed for the particular 
transducer used in the device. Along with the pneumotachograph, Respiratory Inductance 
Plethysmography (RIP) elastic bands are wrapped around the thorax and abdomen to collect lung 
volume data as shown in Figure 2.3. 
 
 
Figure 4: Placement of abdominal and thoracic RIP bands (Howell, 2011) 
RIP bands are calibrated to the horse using the Fleisch pneumotachograph data and set to 
zero voltage when no force is present on the sensors. The bands will increase in voltage as the 
horse’s body expands during breathing, and decrease as the horse exhales. The data from the 
pneumotachograph and the bands are collected simultaneously by a transducer, processed, and 
displayed on the same screen. Both signals are used in conjunction to diagnose possible 
pulmonary disorders, by checking for any characteristic deformations in the graph (Hoffman, 
2002). For example, if the peak of inhalation is sporadic and at a low voltage, there is high 
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likelihood for an obstruction in the pulmonary system. An example of graphs used to diagnose 
disorders are shown in Figure 2.4, where the graph on top represents normal lung function and 
the one below it represents abnormal lung function. 
 
Figure 5: Examples of graphs used for diagnosis. 
 
The slight peak in the pneumotach flow in the bottom image of (2.4) represents a lower 
respiratory obstruction. A series of graphs displaying the data of both the RIP bands and the 
Fleisch pneumotachograph measurements are displayed in (2.5). 
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Figure 6: Representative data from the RIP bands and the Fleisch pneumotachograph in Open Pleth. 
The topmost graph indicates the voltage readings from the RIP bands, the middle graph 
indicates the voltage in terms of volumetric flow after conversions, and the bottom graph 
indicates the difference between the volumetric flow data and the data from the RIP 
bands/Fleisch pneumotachograph.  
 The Fleisch pneumotachograph has the lowest resistance to horse's breathing during rest, 
which provides a significant advantage in producing accurate results and larger pressure 
differentials. However, this comes with the limitation that there is a high resistance during 
exercise, making the results during those trials invalid. Fleisch pneumotachographs are also 
capable of displaying collected data as a graph with a linear output, making the analysis of data 
and diagnosis more efficient. The pneumotachograph is attached to the horse using a facemask, 
adding stability and guiding airflow through the sensor. For young horses or less affected horses, 
FOM is used when collecting data to show how the air moves through the respiratory system. 
Through FOM, sinusoidal waves of air are directed into the horse’s nostrils and through the 
system, creating sinusoidal pressure waves. Through the OpenPleth software, natural pressure 
fluctuations are filtered out(Hoffman & Mazan, 1999). The main output of FOM is impedance, 
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which is the ratio of driving pressure to flow. The lower the flow, the higher the impedance, and 
vice versa. Impedance signals change based on resistance, elastance of the lungs, and inertance. 
Elastance contributes to impedance at low FOM frequencies, whereas, inertance dominates at 
higher frequencies. There is a revealing frequency value that can signify lung function 
abnormalities, with a normal horse at approximately 2.5 Hertz. This will increase given possible 
airway obstructions or abnormalities in breathing rate (Hoffman & Mazan, 1999). FOM is 
advantageous because testing is not time consuming or invasive. Figure 2.6(A) shows the FOM 
device the Cummings School of Veterinary Medicine uses, and Figure 2.6(B) is a schematic 
depicting how the system works. 
 
 
          
Figure 7: Cummings School of Veterinary Medicine FOM device, Figure 8: Schematic of FOM method where 
sinusoidal air waves are forced through the pneumotachograph to the horse’s respiratory system. 
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If the horse is older or has a severe breathing disorder, the respiratory rate too closely 
matches the FOM signals, making the testing method obsolete. Instead, veterinarians utilize a 
passive device by first nebulizing the horse using histamine to restrict the airways and increase 
flow velocity from the lungs through the sensor (M. Mazan, Personal Communication, 
September 30, 2016).  
Some challenges associated with the current setup is saliva accumulating in the device, 
interfering with the sensors which alters the calibration, imbalance of the flow transducer, and 
small amounts of added resistance from the pneumotachograph (Hoffman, 2002). Additionally, 
the data gathered from this passive system is noisy, and hard to decipher by veterinarians easily, 
costing valuable time.  To determine which breaths to actually analyze, inclusion criteria were 
developed by Dr. Andrew Hoffman created inclusion criteria to determine what breaths 
displayed are valid for analysis and diagnosis. For example, if FOM is used, the data will filter 
out frequencies that are not between 5 and 30 Hz per minute, and inspiratory to expiratory 
volume ratios that are not between 0.7 - 1.3. Criteria can also be included that removes tidal 
volumes below 2 L and inspiratory flows less than 1 L/sec. The criteria will not filter out every 
unusable data point and some are still removed manually. The facemasks used on the horse can 
also cause irregular breathing and pressure swings based on minor adjustments and a lack of 
form fitting. 
2.14   Complications when dealing with horses 
Being that horses are very large animals, working around them causes a potential hazard 
to equipment, other animals, and veterinarians in close proximity. Additionally, studies indicate 
that horses may exhibit behavioral problems such as crib biting, weaving, chewing wood, box-
walking, and various other aggressive behaviors (Moore, Millar, Matsuda, & Buckley, 2003). 
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People working around or on horses, regardless of previous experience or training, may become 
victims to bites and kicks without warning. Horse bites can inflict muscle rupture, fat necrosis, 
and severe hematoma depending on the severity of the bite (Moore et al., 2003). In a survey 
completed by 216 Swiss veterinarians, 75% of the vets were kicked by a horse one or more times 
per year (Hausberger, Roche, Henry, Visser, 2008).  When introduced to new stimuli, horses 
typically perform one (or multiple) of the following actions: stepping sideways, swinging their 
head, kicking in the direction of the stimuli, or moving backwards.  Beyond their behavioral 
characteristics and unpredictable nature, horses are non-compliant to human commands, and thus 
cannot follow particular breathing patterns as opposed to humans, that can be directed to take a 
deep breath in, or to exhale fully.  These aforementioned complications make testing, 
diagnosing, and working with horses much more difficult. 
 
2.15    Significance of developing devices for horses 
Chronic obstructive pulmonary disease (COPD) is caused by the delayed hypersensitivity 
response and inflammation of the bronchial tubules, resulting in particle accumulation in the 
lungs, reduced respiratory rate, and ultimately decreased oxygenation of the blood.  The delayed 
hypersensitivity response occurs from antigen formation and frequent particle inhalation 
(Robinson, Derksen, Olszewski, & Buechner-Maxwell, 1996). Stabled horses suffer from 
exposed risk to inhaling large amounts of particles given the recirculation and poor ventilation of 
stables. The humidity in the summer causes antigens such as thermophilic molds and 
actinomycetes to grow in the hay, and when horses breathe in these antigens, neutrophils attack 
the lung causing an inflammatory response (Knapp, Holt, & Lechtenberg, 1975). The antigens 
formed through humid conditions in confined stables, obstructs the airways  and causes 
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nonspecific hyper responses. Mucus accumulates in the airway along with the antigens, causing 
stabled horses to wheeze and cough frequently (Robinson et al., 1996). 
80% of stable horses suffer from Inflammatory Airway Disease (IAD) (Cumming 
Veterinary Medical Center, 2016). Early diagnosis and therapy treatment for young horses with 
IAD is crucial in preventing coughing and heaving to prevent permanent tissue damage, 
especially in racehorses (Wood, Newton, Chanter, & Mumford, 2005). The performance levels 
of race horses with pulmonary disorders, especially in younger horses, significantly decreases 
(Sanchez, Couetil, Ward, & Clark, 2005). The race horsing industry is directly impacted by the 
performance of horses, and the multi-billion dollar industry requires horses to perform at optimal 
levels. Besides the tremendous amount of money through this industry alone, equine veterinary 
care is also costly. Performance race horses require annual veterinarian/medical, with costs 
ranging from $500 to $1,400 per horse (Gordon, 2009). In the state of Kentucky, the amount of 
money that is bet daily on horse races can rise up to $1.2 million, if not higher, for a single race 
track. A 3.5% tax in the United States is issued on horse race bets, providing the government 
significant revenue.  This exorbitant amount of money reflects a significant emphasis on the 
importance of the health of racehorses, sourcing a clear need for diagnosing and preventing 
possible diseases and permanent damage. 
 
2.16 Conclusion 
IAD and other pulmonary disorders can greatly impact the performance and health of all 
horses. Current diagnosis methods are complex, invasive, and expensive, making it challenging 
for horse owners to receive adequate diagnosis and treatment for their horses suffering from 
subclinical lung function disorders. The Cummings School of Veterinary Medicine at Tufts 
developed a non-invasive method to test for lung function abnormalities. This device has proven 
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to be successful, but has some disadvantages as well. The device is heavy and protrudes far off 
the face of the horse, causing a risk of injury to the operator. The device also uses a Fleisch 
pneumotachograph component that is expensive and no longer produced. Our team was tasked 
with developing an improved method of measuring lung function of horses. In the following 
chapter, we discuss our design process to develop an improved method for measuring equine 
lung function. 
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Chapter 3: Project Strategy 
3.1 Initial Client Statement  
 During the first meeting with Dr. Mazan, our team discussed the needs of the Cummings 
School of Veterinary Medicine: an improved and efficient respiratory testing apparatus. This 
follows the work of WPI’s 2017 Equine Respiratory Function MQP team. The initial client 
statement was to develop a lightweight respiratory monitoring system, capable of performing 
with equivalent precision to Tuft’s Fleisch pneumotachograph, and to incorporate RIP band data 
into the LabVIEW program. The following subsections reflect the objectives for the project, 
revised client statement, and overall strategy for completion.  
  
A) Initial Project Objectives 
 
 The overall project objectives after multiple meetings and revisions were compiled into a 
comprehensive list included below:  
1. Validate the Rev C sensor, and test the sensor in controlled environments to simulate 
equine respiratory tests 
2. Validate and update LabVIEW code to convert Rev C sensor outputs to wind speed and 
breathing rate 
3. Incorporate RIP bands in the LabVIEW code to quantify expansion of the diaphragm 
4. Design and test multiple masks meeting the guidelines of Dr. Mazan, and the 
safety/comfort of horses 
5. Research and design a wireless, portable system capable of running the respiratory test in 
the field, without having to be attached to a computer 
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3.2 Project Constraints  
 In the initial meetings with Dr. Mazan, project constraints and concerns were discussed, 
along with the most critical factors to measure and ensure in the design process. The main 
constraints were split into 3 areas of focus: Design constraints, Function Constraints, and 
Safety/Comfort constraints. While some of these topics overlap and relate to each other, each one 
is addressed individually in the following subsections. 
3.2.1 Design Constraints  
 
The first set of constraints comes from the overall mask design. The current fleisch 
pneumotachograph, as mentioned in the Literature Review section is expensive and limited in 
manufacturing. In addition to its expense and manufacturing struggles, the fleisch 
pneumotachograph is heavy, weighing 10 lbs, which poses a risk to people and equipment 
nearby. Additionally a heavy design is impractical as a horse’s neck cannot support the weight 
on its own.  
3.2.2 Function Constraints 
 
 The next stage of constraints are the functional constraints of the current design and the 
required testing outputs in order to be used in clinical applications. The first function required for 
the data output is the lung velocity vs. time during resting. This is measured through the Rev C 
sensor, but requires calibration to minimize sensor noise and to display accurate lung volume 
displacement. In addition to the velocity functionality of the design, it also has to be able to 
attach to a standard halter or bridles for multiple breeds of horses, while still directing airflow 
over the sensor. This is crucial in the design, because if the mask is not capable of adjusting size 
or permeates a significant amount of air, then all results will indicate respiratory conditions. The 
mask design is required to collect spit and moisture accumulation. This encasement must be 
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easily maintained and cleanable. The whole system is required to be sterilized and cleaned after 
each use, while still maintaining form and mechanical properties.  
3.2.3  Safety Constraints  
 
 Safety is a primary concern for both the horses during trials and any surrounding 
personnel conducting the test. The mask must not have any pointed protrusions on the interior or 
exterior of the mask, potentially leading to injury. The mask’s interior must not contain jagged 
edges or rough composites that could lead to cuts and abrasions on the horse’s head. For 
additional safety, the mask must not be heavy, as this would strain the horse’s neck. Keeping the 
mask lightweight also prevents serious injury to surrounding personnel if the horse swings its 
head around. The mesh on the inside of the mask must direct airflow over the sensor, but not 
restrict breathing, swaying results or causing difficulty breathing for the test subjects.  
3.2.4 Code and Regulations  
 
Due to the limited manufacturing and regulations required for the mask design, there are 
no specified codes and regulations for the creation of this project, however, for our project we 
operated under the assumption that we were developing a class 1 medical device, as would be the 
case if we were developing this product for human use. Good Manufacturing Practices are 
required for mass manufacturing of the mask design. When working with horses, it is important 
to consider the fact that they are living beings that are responsive to external stimuli, including 
light, sound, and touch. In the design of the mask housing unit for the flow sensor, those 
considerations must be taken into account. It is important to design all interfaces between 
components and the horse are comfortable and cause no danger from electrical components or 
abrasions. 
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3.3 Revised Client Statement  
 After discussing and evaluating the constraints of the project, we sat with Dr. Mazan and 
redefined the client statement to meet the current needs. This revised client statement is to 
develop a lightweight respiratory monitoring system, capable of performing with equivalent 
precision to Tuft’s Fleisch pneumotachograph, adhering to the safety protocol and design 
constraints explained in the previous sections. 
3.3.1   Revised Project Objectives 
 
 The revised project objectives are concentrated to provide guidance to the project goals, 
and structure for the completion of the project. The concentrated objectives allow for increased 
understanding of the individual components, integral to the design, and allow the full analysis 
and comparison of various materials, designs, and approaches for the optimal project outcome.  
  
1. Validate the Rev C sensor, and test the sensor in controlled environments to simulate 
equine respiratory tests 
o Test multiple Rev C sensors to evaluate accuracy 
o Use compressed air over sensor to test limits of sensor output  
o Compare test airflow with breathing rate by standard rate  
2. Validate and update LabVIEW code to convert Rev C sensor outputs to wind speed and 
breathing rate 
o Compare simulated outputs to controlled flow over sensor 
o Redefine variables and equations to ensure calibration and outputs are consistent 
with Fleisch pneumotachograph outputs 
o Improve User Interface (UI) for broader application and less confusion 
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3. Design and test multiple masks meeting the guidelines of Dr. Mazan, and the 
safety/comfort of horses 
o Research and analyze material properties for the exterior mask design and interior 
mesh 
o Create rough designs and rapid prototype models for application  
3.4 Project Approach 
The project approach was broken down into three separate approach categories to be 
addressed throughout the entire project timeline. Below are descriptions for the approach of the 
LabVIEW code, mask design and fabrication, material selection, and the testing of the final 
design. 
3.4.1 LabVIEW Code Approach  
 
The first stage of the project was to improve the previous LabVIEW code. Prior to our 
project team’s continuation of the Equine Lung Function Testing MQP, we met with the 
previous team to transfer all data and tools so we could build from their foundation. During this 
meeting, we received a large syringe to simulate the lung capacity of a horse, the final report, and 
a Rev C sensor as their final choice in an affordable respiratory measuring tool. 
Firstly, the LabVIEW code required updated user interface (UI) to benefit the operators 
in a clinical setting. To do so, we reduce clutter and overlapping text on the screen, redefine sizes 
of textboxes and user directed inputs. By changing the colors and orientation of the system, and 
increasing the output graph displays, the user experiences less confusion, and will overall lead to 
optimal performance in the field.  
In addition to the UI of the LabVIEW code, we focused on updating the code to eliminate 
redundancies and enhance performance. We eliminated the use of global variables between test 
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cases and the operating program.  Program efficiency was improved, which lead to more 
accurate results. Beyond the UI and the function updates, we send the results of the code to an 
Excel file, with appropriate naming conventions for data analysis. 
 
3.4.2 Mask Design and Prototyping Approach 
 
 We first investigated the client needs and discussed the potential limitations and focuses 
of the mask designs and prototypes. We used Solidworks as the platform for designing mask 
components and fitting it for full size dimensions. We used the 3D printing facilities for 
prototyping and fitting components. We purchased a life-size model head of a horse to ensure 
proper fit and function. Each iteration of the mask was shown to our advisors and sponsor for 
input on potential improvements. The mask was tested to ensure flow can pass through it under 
high pressure conditions. It was tested to ensure that it is comfortable on the head of a horse, and 
that there would be no interference with any components needed for data acquisition. 
3.4.3 Material Selection Approach  
 
 The material selection was conducted by testing the mechanical properties for the exterior 
and interior of the max. This was compared to the need statement and each material was chosen 
with the intent of meeting as many client needs as possible. This includes the comfort, price, 
weight, mechanical strength, flexibility, and reproducibility. 
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3.4.4 Design Validation and Testing 
 
 The design was validated and tested using pressurized air, comparison to literature, and 
client need evaluation. Our final mask housed the Rev C sensor, and compressed air was sent 
through, mimicking the breathing rate of a horse. The values from this were measured and 
compared to that from the Fleisch pneumotachograph, and later compared with human breathing 
trials in a smaller version of the mask. If the design did not measure the same flow rate inserted 
into the mask, errors were marked, and the mask was altered to address the initial concern 
causing the error. The mask was validated based on accuracy and reproducibility of accurate 
readings through the LabVIEW code. 
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Chapter 4: Methods and Alternative designs 
4.1 Needs Analysis 
 This project requires considerable focus and directed needs analysis to determine 
materials, process, and design in order to meet the problem statement and client requirements. 
The following subsections address the process used to evaluate the needs of the client, to help 
shape our decisions throughout the duration of the project.  
 
4.1.1 Current Design Limitations  
 
The current design has multiple limitations that are potential hazards to the horses and 
any personnel or handlers present during testing. The current mask is large, bulky, and heavy, 
and is a danger to the horse’s neck if unsupported, and to people if the horse swings its head. In 
addition to these limitations, the Fleisch pneumotachograph is expensive, which limits resources 
and application outside of the hospital. The current need of the project is to reduce weight/size of 
the mask and provide a cheaper alternative to the current design.  
 
4.1.2 Equine Respiratory Testing Limitations 
 
The current testing parameters limit the applications of this device. During testing, the 
horse must be either sedated or in an enclosed area and it must be attached to a computer for data 
acquisition. The Fleisch pneumotachograph is a wired sensor supported by a veterinary or aide 
during testing. Therefore, the needs arise to help create a wireless system for data acquisition and 
lightweight attachment, capable of supporting itself when placed on a bridle or halter.  
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4.1.3 Design Pairwise Analysis  
 
 The Pairwise analysis is a comparative tool used to test specific characteristics between 
each other to determine the most important traits required for a design/decision. The first row of 
traits is compared to the columns of traits with a 1 or a 0. A value of 1 indicates the trait of the 
row is more important in the design process than the column. Since the trait cannot be 
categorized against itself, it is denoted a null value (X). The totals for each row are totaled and 
compared at the right side of the table.    
Our team utilized a Pairwise analysis based on a discussion with our sponsor, Dr. Mazan, 
to determine the most important characteristics our mask design must accomplish. Below is the 
resulting Pairwise analysis, taking into consideration the 6 traits from our discussion.  
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Characteristic Lightweight Cost Durability Ease of 
Application 
Reproducibility Size Total 
Lightweight  X 1 1 1 0 1 4 
Cost  0 X 1 0 0 0 1 
Durability 0 1 X 0 0 0 1 
Ease of 
Application 
0 0 1 X 0 0 1 
Reproducibility 1 1 1 1 X 1 5 
Size 0 0 0 0 0 X 0 
Table 4: Pairwise Analysis. 
The lightweight trait describes how light the mask design is on the horse; the cost trait 
describes the total cost of materials, manufacturing, and setup; the durability trait describes the 
strength of the material and mask design; the ease of application trait describes how easy the 
mask is to equip on a horse; the reproducibility trait describes the ability to obtain the same 
results and ability to manufacture with the same resulting fit for the horse; the size trait describes 
how small the design must be when attached to the horse.  
The above table was completed with the assumption that accuracy would be the number 
one consideration in the design process with the results of this table following. The number one 
trait determined was reproducibility, indicating that our final design must satisfy an accurate and 
easily reproducible method. After this, lightweight is the second most important trait for our final 
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design. With both of these considerations, we focus our design on the premise of a lightweight, 
and stable device capable of withstanding the movements of a horse during testing.  
 Extra considerations for the design included whether the horse was stationary during the 
test vs. exercising. For stationary testing, the ability for the mask/housing unit to be durable in 
case of flailing and damaging the equipment. While the horse is exercising, the constraint is that 
the mask must be lightweight to reduce air resistance and feel indifferent on the horse. 
4.2 Functions and Specifications  
 The overarching functions of the updated mask design and testing parameters are created 
to meet the needs addressed previously in the aforementioned section. A full list of the required 
functions and specifications are outlined below. 
A.  Required Functions  
 System must relay breathing rate and lung displacement real time for veterinarians 
to diagnose   
 System must output data to Excel for record keeping and displaying graphs  
 Sensor must be capable to wirelessly collect data through external software or 
equipment for future iterations  
 LabVIEW or Matlab code must be capable of incorporating RIP bands in future 
iterations  
 
B. Required Specifications 
 Mask must be less than 1 lbs  
 Mask must be lightweight with a Young’s Modulus less than PVC 
 Mask must not protrude more than 1 ft outside of horse’s head 
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 Sensor must operate with same accuracy of fleisch pneumotachograph (with error 
of 2.5%)  
4.3 Feasibility Study 
 To determine the feasibility of the proposed design and the ability to complete the revised 
client statement/objectives, we complete a feasibility study, investigating the cost, the operation 
parameters, the functions and specifications, and the timeline for manufacturing and completion. 
The team is budgeted $1000.00 USD from both the Department of Biomedical Engineering and 
the Department of Mechanical Engineering of Worcester Polytechnic Institute to complete this 
project. Due to numerous members of this MQP team pursued double major degrees, the timeline 
for this project was extended throughout all four academic terms, beginning in August 2017, and 
concluding on April 20th, 2018 for Project Presentation Day.  
4.4 Conceptual Designs 
 During the first stage of design, our team focused on the functional design of the mask 
with conceptual designs. We used a Kinects model to illustrate the structure needed to support 
the mask on a horse. The first mask was built of kinects pieces to give an estimate of the 
dimensions needed for the upcoming mask iterations. As seen in figures 4.1 (A) and (B), we 
attached a loop to the nose band and horizontal supports to the cheek piece using electrical tape, 
making sure that nothing was resting on or behind the nostrils, due to sensitivity in those areas. 
The pvc tube represents the housing for the Rev C sensor, that is included in the final designs. 
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Figure 9: Kinects Model  
4.5 Preliminary and Alternative Designs  
 Based on the conceptual Kinects model for the mask design, we constructed preliminary 
designs through Solidworks. We planned for the design to be connection to a bridle or halter, 
allowing for a lightweight, universal design, which is reproducible in its application. Figure 4.3 
below indicates the general setup and layout of bridles.  
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Figure 10: Bridle Parts Description  
 
 Based on the setup of the bridle, we opted to follow some 3D printed primary designs to 
fit around the bridle. We 3D printed the first iteration of the kinects design by first converting the 
components to a Solidworks model. From this model we learned that the horizontal supports that 
connect to the cheek piece needed to be angled outward to account for the widening of the horses 
muzzle. We also determined that slots should be put in the horizontal supports to make 
attachment easier for the user. 
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Figure 11: Preliminary Cage Design  
 
Figure 12: 3D Printed Preliminary Design 
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 Our second iteration of the design structured a wireframe cage around the outside of the 
horse’s muzzle. The major difference in this model is the two side hoops that allow for the sensor 
housing and moisture trap to be more effectively accessed and maintained. This model was 
designed in ABS material, weighing just over half a pound, fulfilling the lightweight and sturdy 
requirements. This model also used a more effective connectivity method between pieces, where 
a rod from one part slides into a slot in another part and then is glued together. This provides a 
strong adhesive bond, holding the pieces together. Below is the final iteration of the design that 
was considered before coming to a final design decision.  
 
 
Figure 13: Third Iteration Mask Design 
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Figure 14: Exploded Third Iteration Mask Design 
 
4.6 Material Selection  
4.6.1   3D printer material 
Three dimensional printers use a variety of different materials. Acrylonitrile Butadiene 
Styrene (ABS), Polylactic Acid (PLA), and Nylon are three of the more common materials. ABS 
is the most common material in 3d printing because of the low costs of the ABS filament. ABS 
material is resistant to high temperatures and has strong mechanical properties (3dprinting, 
2017). The major downfall of ABS is that it is a non-biodegradable toxic material and therefor 
releases toxic fumes at high temperatures (3dprinting, 2017). Do to the toxicity ABS is not 
suitable to use with food. 
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PLA is also a very common material in the 3d printing industry. PLA is made from 
renewable resources and is nontoxic. PLA allows for high speed printing and is available in 
many blends such as wood and bamboo (3dprinting, 2017). PLA has moderate prices, but is 
preferred for smaller objects because post processing is difficult and the material is fragile 
(3dprinting, 2017). 
Nylon 3d printing is also moderately priced. Nylon is very durable but also allows for 
flexibility in the part. Nylon prints are UV and chemically resistant. Issues includes expiration of 
the nylon material and a moisture free environment (3dprinting, 2017). 
4.6.2   Carbon Fiber 
Carbon fiber is a very strong polymer that is also lightweight. Carbon fiber is five times 
stronger than steel (ICE, 2015). Although strong, carbon fiber is very lightweight. The material is 
also chemically resistant, tolerant to high temperatures and has low thermal expansion. Carbon 
fiber is typically used in the bicycle, automotive and aircraft industries for the reasons listed 
above (ICE, 2015). 
4.6.3   Stainless Steel 
 
Stainless Steel (SS) has a high elastic modulus and mechanical strength with limited 
flexibility with a Young’s Modulus of 190 GPa (CES Edupack, 2018). In addition to its relative 
strength, SS is also used in the medical field due to its ease of cleaning and sterilization. 
Stainless Steel is also waterproof, preventing any seepage to pass through the material support. 
The disadvantages of this material choice is that it is heavy in comparison to the other materials 
mentioned in this section, and is costly to prepare and mold to specific fitting. SS is not suitable 
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for breathability, but has the capability of directing airflow following the path of the material. 
With this in mind, the only feasible use for this material would be the frame of the mask. 
4.6.4   Plastic Molding  
 
Plastic molding comes in form of heating plastic to an aqueous form and then cooling it 
to sheets or specified orientations. The benefits of plastic molding and a plastic polymer based 
material for design is that it is lightweight, shape-fitting to any form, and can easily direct 
airflow over the material, similar to Stainless Steel. It is significantly weaker than SS, with a 
Young’s Modulus of 160 GPa (CES Edupack, 2018).  However, forming plastic molding 
requires specialized tools and facilities to meet mask component specialization. In addition to 
this disadvantage, the material is not breathable, leaving the only option of this as a support 
material for the frame. 
4.6.5   3-Ply Medical Grade 
 
 In common medical practices, a 3-ply filter mesh is used as personal protective devices 
and to prevent flow intake. This 3-ply non-woven mesh offers unidirectional filtered flow, 
breathable for both phases of the respiratory cycle (3M, 2018). Considering this material is made 
for controlled breathing and airflow, this material is capable of providing a mesh support leading 
to the sensor, but does not have the capability of preventing water accumulation or directing 
airflow over the sensor.  
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4.6.6   Neoprene Fabrics  
 
 Neoprene fabrics are used frequently in scuba materials and wind resistant jackets due to 
its hydrophobicity and multilayer woven form. The high number of layers and material 
composition create a solid barrier to the external environment, preventing significant wind from 
passing through, and providing protection from water. This material is high in tensile strength, 
and requires hand washing. 
 
4.7 Mask Testing 
4.7.1   Mechanical Testing  
 To measure the effect of the mask, we test various materials to determine the structural 
integrity, the shape capability, and the weight of the structure. Firstly, we measured the 
mechanical properties for the external support of the mask using a 3pt bending test in an Instron 
5543, provided by WPI Department of Biomedical Engineering. Through this testing, we 
examine the Young’s Modulus, the fracture resistance, the pliability of the material, and the 
force displacement of the material. Primarily, we compare the strength of the material of the 
Young’s Modulus and the weight to examine possible support material. The optimal material is 
then selected after all of the materials are compared. After the support material is tested and 
selected, we use tensile testing with the Instron 5543 to measure the mesh’s mechanical strength 
and flexibility.  
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4.7.2   Interior Mesh Testing   
 
Beyond the flexibility and tension test, we conduct a contact angle test on the mesh 
materials, checking for water hydrophobicity to prevent water accumulation and increased 
humidity in the mask. When the contact angle test was finished, we created a human sized mask 
to mimic the full size horse mask, and use it to check comfort and breathability. A syringe 
mimicking the lung capacity of horse was used to pass air through a stretched portion of the 
mesh while it was covering the mask to simulate live breathing conditions. This was done to test 
if a significant amount of air could pass through the mesh without passing through the sensor, 
which would result in the material needing to be re-evaluated in order to find a more suitable 
material. 
4.8 Sensor Selection  
This year’s design team used a hot-wire anemometer sensor to continue where last year’s 
team left off. The previous year’s team had looked into 7 different sensor types before coming to 
this conclusion, these included: 
 
 Improved Fleisch Pneumotachograph 
 Three-cup anemometer 
 Hot-wire anemometry 
 Mesh strain gauge 
 Venturi meter 
 Pilot tube 
 Silicon airflow sensor  
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A few of these sensors were promising with the initial research they conducted, however 
each had their issues ultimately leading to the choice of a hot-wire anemometer. The issue for 
hot-wire anemometry is the effect humidity can have on the sensing element. (Durst, 
Noppenberger, Stil, & Venzke, 1996). Research shows that not incorporating humidity will result 
in an error in the velocity reading of 1-5%. To adjust for humidity, there is a correction factor to 
Nusselts number using Reynold’s number and temperatures as shown in the following equation: 
 
 Nu = (0.24 + 0.56*Re*0.54)[ Tf Ta ] 0.17[1 + Ax + Bx 2 ] 
 
 Despite humidity being the major concern of our mechanical advisor, the literature 
illustrates that humidity is not a concern for hot-wire anemometry measurements and provides an 
equation to correct for humidity. The literature provided the team with the ability to pursue this 
design by addressing the major concern of our mechanical engineering advisor.  
The sensor is the Rev C wind sensor for the Modern Device due to its low cost, 
compacted size, arduino integration, and testing performance. Calibration of this specific sensor 
is within the code provided by Modern Device. This sensor measures temperature changes that 
are converted to wind speed in MPH (Modern Device LLC., 2017). After calibrating and testing 
each, the previous year’s team determined the Rev C was the most feasible. Therefore, the 
current project team used the same sensor.  
  
52 
 
4.9 LabVIEW Code Methods  
 The LabVIEW code is a continuation of the code from last year’s MQP team. The code 
incorporates the Bernoulli Equation to demonstrate simulated laminar fluid flow over the sensor. 
The code includes a conversion equation to change the voltage output from the velocity of the air 
over the sensor to Volume over time. By graphing the data and plotting it against time, we were 
able to determine the breathing volume per breathing cycle. This was then compared to previous 
breaths and standards in the literature to examine any respiratory abnormalities present. The code 
incorporates a calibration equation to amplify the small voltages, and reduce the signal noise of 
the sensor. The approach for improving the code are outlined below: 
 Change colors from display diagrams to neutral  
 Resize text and displays to fit all inputs and graphs on single screen without scrolling  
 Remove global variables for improved performance  
 Check calibration functions to ensure optimal conversion  
 Create case function for calibrating sensor  
 Reorganize LabVIEW wiring for cleaner presentation and condensing information 
 Export data to Microsoft Excel file at user’s specification  
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Chapter 5: Design Verification and Results 
 
5.1 Material Selection and Decisions  
5.1.1   Structural Material Considerations  
 
i)  Stainless Steel Considerations 
 
The first type of material we assessed for the frame was Stainless Steel (SS). As 
discussed in the previous chapter, SS has a high Young’s Modulus, yielding high mechanical 
strength and minimal bending. However, SS is dense and has a high weight per cubic foot (CES 
Edupack, 2018). In addition to this, it requires specialized heat treatment and molding to reach 
the desired shapes. Considering the needs statement from D.VM. Mazan, it was apparent that this 
material is not suitable for application.  
ii) Plastic Considerations  
 
 The second type of material we investigated for the frame was plastic. Plastic copolymers 
have a range of strengths and flexibility depending on fabrication for application. In addition to 
its ability to be fabricated to a specific structure and size, it is lightweight and water resistant. 
However, while researching applications for our final design, creating specific molds for this 
application were beyond our budget, and requires specific manufacturing at a separate facility. 
Due to this constraint, this is not a suitable material for our timeline or budget. This is a potential 
material and application for mass producing the mask design.  
iii) 3D Printed ABS Considerations 
 
 The final material consideration was 3D printed ABS. This material is capable of high 
mechanical shape and formatting to whatever shape is desired within the dimensions of a 3D 
printer. WPI offers three 3D printers on campus, capable of printing 10” X 10” 3D printed 
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materials through a Solidworks model. These materials can be infused with Carbon Fiber to 
increase their mechanical strength. Considering the availability and ability to easily manufacture 
parts, and maintain structural integrity, 3D Printed ABS is a suitable material for the structure of 
the mask.  
5.1.2   Internal Mesh Material Considerations  
i) 3ply Medical Grade Mesh  
 
 Initially, we investigated the properties of 3 ply medical grade respirators used in 
hospitals around the United States. These are designed with 3 layers of varying mesh thicknesses 
to filter air intake. This material prevents splatter of blood or water from entering the mask, but 
does not prevent significant amount of water accumulation. In addition to this limitation, the 
mesh is not capable of directing airflow due to its primary design purpose of filtering air intake. 
These limitations remove this as a potential material for the external mesh, however it may be 
used as an interior lining protecting the sensor.  
ii) Neoprene Fabric  
  
 Neoprene fabric is often used in scuba materials due to its water and air resistance. Air is 
not capable of passing through the material easily, and in addition to this, the material is 
hydrophobic. Neoprene has high elasticity and tensile strength. These advantages make 
Neoprene a solid material choice to be added to the internal mesh of the mask design.  
5.1.3  Final Material Decisions 
 
Due to limitations on finances and time, in addition to the considerations accounted for in 
the previous subsections, we made our final material decisions before mechanical testing 
validation. We selected 3D printed ABS for the external support material and Neoprene fabric to 
be sewn together for the interior lining. In the neoprene mesh, we sew in Velcro straps to attach 
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to the bridle for stability. The components of the mask were glued together using an epoxy 
adhesive, granting solid connection of all pieces.  
5.2 Material Testing  
5.2.1 3D Printed Material Testing 
3D printed Acrylonitrile Butadiene Styrene (ABS) is tested using an Instron, to report the 
testing of the forces, yield, and failure of the material under maximum load calculations.  
5.2.2 Internal Mask Material Testing 
The final material selected for the mask internal shielding was Neoprene Heavy Scuba 
Knit by Mood Fabrics. The material was selected based on its limited permeability and strength, 
ability to prevent air from escaping, and the protection it would provide the sensor. This material 
was tested using an Instron, to report the testing of the forces, yield, and failure of the material 
under maximum load calculations.  
  i) Force Testing  
Below are the data for the tensile testing test for the fabric. Figure 5.1 indicates the force 
vs. displacement graph throughout the entire trial, and Table 5.1 shows all significant data 
gathered from the test. 
 
Figure 15: Neoprene Force vs. Displacement 
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Table 5: Neoprene Tensile Test Data 
 ii)  Hydrophobicity Testing 
 
The following test was conducted to determine the hydrophobicity and water resistance 
of the material to prevent spit and phlegm from the horse from accumulating on the inside of the 
mask. We tied a segment of the Neoprene fabric over an open cup and secure tightly with a 
rubber band to simulate the sewn final product. A drop of water is placed on the fabric and an 
external software ImageJ is used to calculate the angle between the base and the edge of the 
drop. The larger the contact angle, the higher the hydrophobicity. Figure 5.2 below illustrates the 
image sent in to ImageJ.  
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Figure 16: Neoprene Hydrophobicity Test 
 
 Plugging this into ImageJ resulted in a contact angle of 103 degrees, indicating 
hydrophobicity. This application allows for increased water resistance for the interior of the 
mask. After the contact angle was calculated for the mask, we tested the effects of water on both 
sides of the mesh to examine the time dependent properties of water on mesh. We followed the 
same procedure of the contact angle test, and let a 100 mL sample of water rest for 5 minutes on 
both the superior and inferior surface of the mesh. Figure 5.3 below shows both sides of the 
fabric after the 5 minute test.   
 
Figure 17: Hydrophobicity Test after 5 Minutes 
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 Notice the right side of the test, holding the material for the interior of the mask. This is 
significantly more hydrophobic and holds the water without significant absorption. However, the 
left side of the test shows the internal absorption possible with the flip side of the mask. Due to 
this difference, we ensure that the design has the hydrophobic side on the interior of the mask for 
easy cleaning and minimized bias. 
 
5.3 Design Optimization  
 
 The design was optimized through the remodeling of mask components to allow for 
increased strength and structural integrity. Various thicknesses of support brace and connection 
points are tested between each iteration. To optimize performance and design, we focused on 
creating a system that met our criteria: lightweight, reproducible, and sturdy. With this in mind, 
we increased the diameter of the support spans by up to 30%, increasing overall toughness to 
support 70 lbs of contact force.  
 
5.4 Design Modeling  
 The design was modeled with the use of various techniques to simulate overall look, 
function, and attachment locations. We modeled the design in the first iteration with a Kinetics 
model, then transitioned to a Solidworks model, following the dimensions of a life-sized horse 
replica. After the first Solidworks model is 3D printed, future iterations were created by altering 
diameters, component layouts, and shape fitting. The neoprene fabric was traced to surround the 
interior of the 3D printed mask. The edges were stitched together and Velcro straps were 
attached to the mesh to bind it to the mask frame. 
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Chapter 6: Discussion 
 
6.1 Results and Objectives 
The result of this project was a functioning respiratory diagnostic system with a form 
fitting mask. The Rev C sensor is an effective flow monitoring device capable of determining 
respiratory disorders in horses. Based on improvements to the previous LabVIEW code from last 
year, and testing with compressed air, we determined that the sensor and system as a whole acts 
within +/- 6.00% accuracy. The design is lightweight, totalling 0.91 lbs, and costs a fraction of 
current technologies. Considering that the design can be manufactured with varying component 
sizes, our design can be made for any breed of horse, with minimal resistance.  
There are some limitations present in the design based on the fabrication and testing 
available. Throughout the testing process, we were not able to test the system on a live horse. 
Instead, we used simulations based on compressed air and human testing to determine the 
effectiveness of the sensor and mask. Future testing could determine the comfort of the mask and 
comparison to the fleisch pneumotachograph. In addition to this limitation, the RIP bands were 
not operable throughout the year, so they could not be added to the system.  
6.2 Economics 
 
The economics of the project are divided into three main categories: Sensor purchasing, 
Mask design, and Material components, each of which are addressed below. 
  
60 
 
6.2.1 Sensor Purchasing Cost 
 
As discussed in the Rev C sensor section of this report, the sensor is purchased through 
Modern Device. The total cost of the sensor is $17.00 USD before taxes for United States 
shipment. Any additional costs are determined based on the international export of the sensor. 
 
6.2.2 Mask Design Cost 
 
The mask design, composed of 3D printed ABS is relatively inexpensive, and determined 
specifically by the size of the overall mask. Based on our trials, we created three different sized 
mask components, ranging in size to fit numerous horses. The final cost for this design ranges 
from $80 to $120 USD. 
 
6.2.3 Material Component Cost 
 
The final economic consideration for this project is the external materials used for 
fixation and housing the sensor. The neoprene fabric comes in a large supply through Mood 
Fabric, costing $45.00 USD, for each 6 X 6 ft. sheet. This is capable of creating up to two masks 
with some remainder for error correction. In addition to the neoprene components, we use velcro 
strips to connect to the halter/bridle for the horse. We purchased velcro strips through AC Moore 
for $5.00 USD. 
 
6.2.4 Total Cost 
 
The total cost of the design came from adding all of the components of the previous 
sections. The total cost is approximately $150.00 with slight variance due to size for the horse’s 
head. 
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6.2.5  Mass Production Cost 
 
           Mass production reduces the cost significantly per mask when the mask components are 
molded to fit, and sent through production facilities. Due to the limited scope and application of 
this project, there currently is no need to mass produce this design. In future iterations and 
applications of this project, if it is to continue in future years, team members can reach out to 
facilities to produce the fabric and design much faster and cheaper. 
6.3 Environmental Impact 
There are minimal environmental impacts concerned with this project due to the relative 
small scale of application and manufacturing. The components are all purchased through outside 
vendors, and the main manufacturing piece is 3D printed ABS, which does not produce 
significant weight for the design.  
6.4 Societal Influence  
There are no significant societal influences present in this project. Due to the limited 
scope of the project, there is minimal societal impact of the project. This does not interface with 
humans, and does not pose as a societal concern.  
6.5 Political Ramifications  
There are no significant political ramifications present in this research and project.  
There are no patent disputes discovered, endangerment to animals, or concerns to be discussed 
on the political aspect.  
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6.6 Ethical Considerations  
There are no significant ethical concerns present in this research and project.  
There are no ethical disputes, concerns with impact to animals or humans, environmental 
concern, etc.  
6.7 Health and Safety Issue 
Due to the scope of the project, the health and safety issue of this project reflects the 
interface of the horse. The voltage required to operate the sensor and the DAQ box is minimal, 
and poses no risk to the animal during testing. The low mask weight reduces risk of injury to the 
horse as well as people present during testing. 
6.8 Manufacturability  
This design is manufactured in multiple stages, including the 3D printed exterior, mesh 
sewing, and attachment. The exterior of the mask is manufactured through three separate 
Solidworks models printed to one of the specified sizes for the size of the horse. The components 
are connected together, as described in the User Manual section of the Appendix. Manufacturing 
was completed on WPI campus using the available 3D printers and a sewing machine. For large 
scale applications, manufacturing sources may vary to reduce cost and provide sufficient design 
requirements.  
6.9 Sustainability  
The project has a sustainable initiative, and does not produce significant waste. The 
interior mesh is reusable for numerous uses and is hand washable for cleaning. The frame is hand 
washable in between trials. The sustainability concerns are limited to the excess produced from 
the Rev C sensor and neoprene fabric companies.   
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Chapter 7: Final Design and validation 
7.1 Final Mask Design  
 The final mask is composed of an external circular frame to fit around the mouth of 
different sized horses, along with a bracing support beam on both sides to keep the frame sturdy 
and fixed throughout the testing process. Two support rods are extended from the base of the 
mask to connect the mask to the horse’s halter. The circular frame, horizontal and vertical side 
supports and the mask extensions are secured using ABS cement which virtually makes the four 
parts into one. The four parts in the middle, being the top and bottom supports and the middle 
supports are inserted in slots or onto cylindrical rods and then zip tied on so that they can be 
easily removed. The middle parts can be printed in different sizes so that the mask can fit 
different horses.  
 
Figure 18: Final mask design 
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Figure 19: Final mask design. 
The major difference with the final mask was making the circular frame 0.4 inches in 
diameter which was an improvement from the previous mask at 0.25 in in diameter. Another 
change was making the slots in the circular supports .2 in deep so that the support that holds the 
sensor cannot push through the circular support. The tolerance for the hole that holds the sensor 
holder is so low that the sensor holder can stay in place while being used but then can also be 
removed if necessary. The goal with the final mask was to make it rigid around the nostrils of the 
horse to protect the sensitive areas of the horse, but then also provide some flexibility in case the 
mask is slammed into any objects by the horse. The flexibility was created with the mask 
extensions which are angled slightly out so that if they are bumped there is some room to move.  
Another perk of the final mask is the slots in the top support incase an extra strap is 
added. The extra strap would just provide even more support and take weight off of the horse’s 
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nose. The final 3D-printed mask only weighs .67 pounds and with the neoprene liner is still 
under one pound. 
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Chapter 8: Conclusions and Recommendations 
 
8.1 Future Recommendations 
Our mask design is a viable option for the respiratory testing of horses for diagnostic 
purposes, due to the testing results of the Rev C sensor and the human trial of the breathing rate. 
However, there are multiple future considerations for the improvement of this design. These are 
included below for the benefit of any future iterations or applications of this design. 
8.1.1  Component Selection and Mass Production 
 
 The first consideration is changes in material selection for the frame of the mask. While 
our material choice of 3D printed ABS is structurally sound and capable of being cleaned, this is 
not the easiest to mass produce or sterilize between trials. During our testing and selection 
process, we discussed the potential use of stainless steel for its mechanical strength and ease of 
sterilizability.  
Stainless Steel (SS) has a high Young’s Modulus, and fracture resistance making it a safe 
for application to the mask. In addition to its strength and ease of sterilization, it has the 
capability of being mass produced with high quality as a single component. With all of the 
components designed together, structural integrity of the mask increases, preventing cracking or 
potential breaks if expressed to high forces. However, SS is limited due to its weight. The 3D 
printed ABS we used in the mask has a density of 1.27g/cm^3, whereas SS has a density of 8 
g/cm^3. The total mask weight with components comes to 0.91 lbs. Our sponsor Dr. Mazan 
impressed the importance of a lightweight design. Due to this, further material selection may be 
discussed for the continuation of the project to meet clinical and distribution needs if this is to be 
taken to mass production.  
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8.1.2 Wireless Connectivity 
 
Wireless connectivity was one consideration for equine respiratory monitoring that we 
intended to address. Due to the limited timeframe for the project, the function and applications 
were researched but not implemented in the final product.  
To achieve wireless connectivity, we suggest the use of an Arduino UNO due to its 
analog inputs and data collecting capabilities. In addition to its strength in computing, the 
Arduino is capable of collecting data wirelessly by using a AA battery attachment and the USB 
port present on the system. The AA battery attachment allows the Arduino to function without 
connection for up to 2 hours, significantly longer than any equine respiratory testing requires. 
The use of a 32Gb or greater USB is capable of gathering more than the 20 minutes required for 
standard equine respiratory testing. Future iterations of this research and product can use these 
resources to apply wireless data acquisition.  
 
8.1.3 Integration of RIP Bands  
 
Following the wireless data collection, a future recommendation for this project 
originally intended for this project was the incorporation of Respiratory Inductance 
Plethysmography Bands (RIP). Due to system malfunction of the operating RIP bands in the 
beginning of the year, integrating the RIP bands with the respiratory display was not within the 
scope of the project. As a potential direction for the future of this project, the following 
discussion provides the framework for potential inclusion of the RIP bands: 
The RIP bands owned by Tufts are connected with AO pins, capable of connecting to an 
Arduino or other data acquisition method. Combining the wireless connectivity discussed above 
68 
 
with the extra pin of the RIP bands creates another channel for measuring breathing function. As 
discussed in the Literature Review section, the RIP bands measure the voltage displacement of 
the bands, and relate that to volume displacement of the diaphragm. Professionals are then able 
to compare these flow loop graphs with standard values for healthy individuals, whether animal 
or human.  
8.1.4 Display Software and Operation  
 
The software utilized for data collection and analysis for this project was LabVIEW. The 
output of this software presents the operator with a live feed of breathing rate vs. time. Within 
the LabVIEW code is calibration equations that convert the voltage displacement from the Rev C 
sensor to approximate breathing rate. All of the data is exported to an excel file to be analyzed 
individually if the operator desires. Future iterations of this project can output the Excel (.csv) 
file to Matlab for a simple function presenting the full respiratory test with overlaid graphs, 
minimum and maximum levels of breathing rate, etc. With this, veterinarians and individuals 
will only have to run the function once per trial after all the data is collected. The drawback of 
this method is that the Matlab software is costly for individuals to purchase. As a clinical 
method, this may be beneficial, as there is minimal debugging required if a well-written, 
commented code is presented.  
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Chapter 10: Appendices  
Appendix A: Mask Drawings 
 
 Figure 20:  Drawing of final side support. Used as vertical supports on each side of the horses 
muzzle 
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 Figure 21: Drawing of final horizontal support. Used on each side of the horses muzzle as 
horizontal supports. 
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Figure 22:  Final Mask Views 
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Figure 23: Drawing of Mask Extension. Used to connect the mask to the halter. 
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Figure 24:  Drawing of Left Nose Hoop. One of the two main supports for the mask. 
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Figure 25: Drawing of Right Nose Hoop. Same as Left nose hoop, other major support for the mask. 
82 
 
 
Figure 26: Drawing of mask support. Connects the two halves of the mask and provides rigidity. 
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Figure 27: Drawing of neck bar. The part of the mask that goes under the horse’s neck and provides 
stability for the mask. 
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Figure 28: Drawing of the nose rest. The nose rest is the major weight bearing part for the mask. The 
radius of the part is former to fit a typical horse.  
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Figure 29: Drawing of the sensor housing holder. This part supports the housing for the sensor as well as 
also providing rigidity for the mask in the most important area, around the horse’s nostrils. 
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Figure 30: Drawing of the Sensor Housing. This part holds the sensor in place and also funnels the 
breaths from the horse towards the sensor. 
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Appendix B: Bag Drawing 
 
Figure 31: Final Bag Drawing 
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Appendix C: LabVIEW Front Panel 
 
 
Figure 32: Front Panel of the LabView Program.  
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Appendix D: Human Mask 
 
Figure 33: View of the Human mask used for testing. 
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Figure 34: View of the Human mask used for testing. 
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Figure 35: View of the Human mask used for testing. 
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Appendix E: Mask Instructions 
1.) Apply ABS Cement to L shaped end of Final_Horizontal_Side_Bar and insert into rectangular 
slot of Final_Mask_Left_Nose_Hoop 
2.) Before previous step dries, apply ABS cement to the 3 holes of the Final_Side-Support and attach 
to the ends of the Final_Mask_Left_Nose_Hoop and to the cylindrical end of 
the  Final_Mask_Side_Bar 
3.) Repeat first two steps for the Final_Mask_Right_Nose_Hoop 
4.) Let dry for 15 minutes or until completely dry 
5.) Insert Final_Mask_Support_1 into bottom slot of Final_Mask_Left_Nose_Hoop 
6.) Insert Final_Sensor_Holder_Holder into top slot of Final_Mask_Left_Nose_Hoop 
7.) Press Final_Mask_Right_Nose_Hoop onto the Final_Mask_Support_1 and 
Final_Sensor_Holder_Holder 
8.) Firmly press mask together  
9.) Slide Final_Nose_Rest onto the the top cylindrical ends of the  Final_Mask_Left_Nose_Hoop and 
Final_Mask_Right_Nose_Hoop 
10.) Slide Final_Neck_Bar onto the bottom cylindrical ends of the  Final_Mask_Left_Nose_Hoop and 
Final_Mask_Right_Nose_Hoop 
11.) Zip-tie tightly the Final_Mask_Support_1, Final_Sensor_Holder_Holder, Final_Nose_Rest, and 
Final_Neck_Bar onto the Final_Mask_Left_Nose_Hoop and Final_Mask_Right_Nose_Hoop 
using the appropriate slots provided 
12.) Insert Final_Sensor_Housing into Final_Sensor_Holder_Holder as far as allowable 
13.) Using the ABS cement attach Final_Mask_Extension to the cylindrical end of the 
Final_Horizontal_Side_Bar making sure the extensions are angled out and parallel to the 
Final_Horizontal_Side_Bar 
14.) Let mask dry 
15.) Apply half of a velcro strip to the outside of the Final_Sensor_Housing protruding into the mask 
16.) Insert Neoprene lining into the completed mask and attach with the velcro loops 
 
Attaching to the bridal  
1. Slide the mask of the muzzle of the horse 
Final_Nose_Rest should side above the nostrils and Final_Mask_Extensions should be connected to the 
bridle using velcro   
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Appendix F: Low flow wind tunnel SOP 
1. Connect cemented reducers to reducing coupling at end of wind tunnel 
 
 
A. B. 
Figure 36: A) reducers attached; Figure 37: B) Reducers unattached from reducing coupling 
 
2. Use a threaded nipple to connect the reducers to the top of the rotameter 
3. Connect an airline hose to the bottom of the rotameter 
 
 
Figure 38: threaded nipple and airline hose attached to 
rotameter 
 
4. Connect the ball valve to the rotameter with the hose 
 
 
Figure 39: Ball valve attached to rotameter via airline hose 
 
5. Use another airline hose to connect the ball valve to the regulator 
 
 
 
94 
 
 
Figure 40: Ball valve connected to regulator via airline 
hose 
 
6. Ensure the regulator is closed and the ball valve is closed 
 
 
A. B. 
Figure 41: A) Regulator in closed position; Figure 42: B) Ball valve in closed position 
 
7. Use the quick disconnect to connect the airline to the regulator 
 
 
Figure 43: Male quick disconnect of regulator that interfaces with compressed airline 
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8. Use electrical tape to secure the sensor at the end of the wind tunnel with the 
sensing element in the center of flow 
 
 
Figure 44: Rev C sensor secured at end of wind tunnel 
 
9. Connect the sensors wires to the correct ports of the DAQ box (see Appendix L 
for detailed instructions) 
10. Hold the hot wire probe or Hold Peak handheld anemometer in the center of flow 
(see Appendices I and J for instructions on use) 
11. Start running the software programs to collect data as described in (Appendix L and J) 
12. Open the regulator completely by turning the cap on the top 
13. Regulate the flow by slowly opening the ball valve until desired pressure and thus 
flow rate is reached 
 
 
Figure 45: Ball valve completely open 
 
14. Stop the flow by returning the ball valve back to the closed position 
15. Disassemble the wind tunnel by following these steps in reverse 
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Appendix G: SOP for single calibration LabVIEW program 
 
Policy: This SOP will comply with veterinary standards and guidelines for external 
device sterilization and equine testing. 
 
Purpose: The purpose of this SOP is to ensure safe and proper setup of the wind sensor 
lung function testing device for reliable and repeatable results. 
 
Scope: This procedure is for veterinarians using the wind sensor lung function testing device to 
diagnose pulmonary disorders. 
 
Prerequisites: 
 Wind sensor system 
o Including: Rev C sensor with 4 wires attached and a 5V wall wart connected 
to the sensor and a ground wire 
 USB-6000 DAQ box 
 1.5 in. rubber connector (housing) 
 Plastic face mask for the horse 
 2.4 mm flat head screwdriver 
 Electrical tape 
 Scissors 
 Paper towels or rag 
 70% ethanol for disinfecting the housing 
 Computer with LabVIEW 2015 software (or newer) and USB port 
 Electrical outlet 
Procedure: 
System setup 
1. Connect wires to DAQ box using the following steps (a-d) 
 
Figure 46: DAQ box used with the system; wires insert into the side below screws 
 
a. Ground (GND) of the sensor (1st pin) should be in one of the ports marked by an 
arrow (AI GND) 
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b. The ground (V+ GND) of the power supply should be in another port marked by an 
arrow (Ai-GND) 
c. The RV pin on the sensor (4th pin) should be connected to port Ai0 on the DAQ box 
d. The TMP pin on the sensor (5th pin) should be connected to port Ai1 on the DAQ box 
 
 
A. B. 
 
 
C. 
 
Figure 47: A) Sensor with pins on left; Figure 48: B) DAQ box ports with labels; Figure 49: 
C) Schematic of Rev C sensor with labeled pins to corresponding DAQ box ports 
 
i. All pins are connected by inserting the exposed end of the wire into the 
respective port and then tightening the port (clockwise) using the 2.4 
mm flat head screwdriver 
ii. The wires can typically be left attached, so check if they are secure with 
a soft pull on each 
1. If it comes out: loosen screw (counterclockwise) with 2.4 mm 
flat head screwdriver, insert the wire, and re-tighten the screw 
2. Insert housing in face mask 
a. Locate the rectangular slot on the rubber connection 
b. Orient this slot so that it will point up when attached to the mask on the 
horse 
c. Insert the rubber connector (duct taped side) into the PVC portion of 
the mask ensuring the slot is closest to you when you slide it on 
i. Lightly tug the device or shake the horse face mask to ensure the 
housing is securely attached 
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3. Insert wind sensor in housing 
a. Slide wind sensor into slot in housing until the wires on the wind 
sensor rest on the stop (extended piece of rubber on the housing) 
 
 
Figure 50: Sensor in housing in mask 
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b. Using scissors cut a piece of electrical tape 1 inch in length 
c. With the piece of electrical tape, tape the four wires from the wind 
sensor to the stop 
3. Plug 5 V wall wart into an electrical outlet 
 
Figure 51: Wall wart plugged into electrical outlet 
 
5. Plug USB cable from DAQ box into computer’s USB-port 
 
 
 
 
Figure 52: DAQ box connected to computer via USB 
 
LabVIEW Setup 
1. Power on computer with LabVIEW 
2. Open LabVIEW 2015 or newer 
3. In LabVIEW: File -> open -> Final_RevC_2.vi 
4. Check to make sure the DAQ box is connected properly and turned on (should see 
blue light on the side of the DAQ box) 
 
Calibrating the device to the room 
1. Use the down arrow on the ringer (labelled ring) to choose the zero-calibration program 
 
 
A. B. 
Figure 53: A) Ringer used to choose which program is running; Figure 54: B) Programs that 
can be chosen 
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2. Click the run arrow (highlighted in image below with a red box) in the upper left 
hand corner right below edit on the toolbar 
 
Figure 55: Run arrow on upper left of screen when in LabVIEW 
 
3. The windspeed MPH should be displaying NAN when the program when started 
 
Figure 56: Desired start conditions for the zero-calibration program 
 
a. If it is not reading NAN click the stop button and ensure everything is connected 
properly before rerunning the program 
4. The program will stop on its own once reaching a wind speed less than 0.0005 MPH 
 
 
Figure Figure 57: Desired end condition (zerowindadjustment factor will vary with test 
environment) 
 
a. Note: For a 5 V wall wart, the adjustment factor should be approximately 0.30- 0.40 
i. If the program does not stop and the windspeed is reading higher than 0.0005 stop 
the program using the stop button 
ii. Check the setup and rerun the program 
5. Once the program stops running keep the LabVIEW Final_RevC_2.vi open 
 
Horse setup 
1. Put the mask on the horse’s muzzle by holding the black rubber cover back and sliding 
it on 
2. Release the rubber seal and allow it to fit tightly to the horse’s muzzle 
3. Attach the blue Velcro strap over the horse’s head to keep the mask on 
 
Testing the horse 
1. Check that Final_RevC_2.vi is still open in LabVIEW 
a. If not, go back to “Calibrating the device to the room” and follow steps again 
2. Use the arrow on the ringer (labeled ring) to select the test program 
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Figure 58: Ringer setting for testing 
 
3. Set file name by editing existing or browsing for a file using the folder button 
a. The file type must be .xls 
b. Program will produce an error if file is open when trying to run the program 
 
Figure 59: Define file path or choose a file by browsing 
 
4. Click the run arrow in the upper left hand corner as done before 
a. Note: data does not automatically begin saving 
5. Click the save button to begin recording data 
 
 
Figure 60: Click this button to stop or start saving (currently not saving, light changes to 
brighter green when saving) 
 
6. To stop saving click the save button again 
7. If finished testing stop the program using the stop button 
 
Figure 61: Use this button to stop the test program; it will not stop on its own 
 
8. Your file will be saved in the location specified with the defined filename 
9. Open the file and save as an .xlsx file before analyzing 
a. When opening an .xls file, Excel will produce a warning message. Select “Yes” to 
continue 
 
Figure 62: Excel warning message 
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System disassembly 
1. Unplug 5 V wall wart from electrical outlet 
2. Horse face mask disassembly 
a. Detach blue Velcro strap from horse’s head 
b. Slide face mask off of horse’s muzzle 
3. Wind sensor housing disassembly 
 . Take off electrical tape from wind sensor wires 
a. Slide wind sensor out of the slot 
b. Slide housing (rubber connector) off of horse face mask 
4. Close LabVIEW 
5. Unplug DAQ box USB cable from computer USB port 
6. Optional: Wire removal from DAQ box 
 . Unscrew each DAQ box screw (4 total) with a wire attached (2 GND, Ai0, Ai1) using 
the 2.4 mm flat head screwdriver (counter clockwise) 
 
Cleaning system after testing 
1. Spray 70% ethanol disinfectant onto paper towel (or rag) 
2. Wipe down housing (rubber connector) 
3. Set housing down to dry 
 
4. Spray 70% ethanol disinfectant onto a new paper towel (or rag) 
5. Wipe down horse face mask 
6. Set horse face mask down to dry 
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Appendix H: Cost Breakdown and Budget  
 
Table of Costs 
Rev C Sensor  $ 17.00 
Neoprene Fabric  $ 47.84 
3D Print of Mask (Prototypes) $ 245.00 
3D Print of Mask (Final) $ 100.00 
Horse Head Model $ 97.00 
Total Cost: $ 506.84 
Total Budget:  $ 750.00 
Remainder: $ 243.16 
 
Table 6: Cost Breakdown and Budget 
  
Preface 
The following paper is in fulfillment of the Professional Writing degree requirements for 
David Frederick. This paper will examine human lung function and the symptoms, detection 
methods, treatment, and epidemiology of three human respiratory diseases: Asthma, Chronic 
Obstructive Pulmonary Disease, and Pneumonia, as well as emerging respiratory health 
concerns. 
 
Anatomy 
 
The human respiratory system is composed 
of the nose and nasal cavity, pharynx, epiglottis, 
larynx, and the lungs. The pharynx is the membrane 
lined cavity behind the nose and mouth, and 
directly below it is the epiglottis, a cartilage flap 
that covers the opening to the trachea. The larynx, 
also known as the “voice box”, is a hollow 
muscular organ that contains the vocal cords. 
Air passes through the larynx to the trachea and 
lungs. The trachea is a cartilaginous tube thats 
primary function is to transport air to the lungs. 
Within the lungs are a network of bronchi, 
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arranged in a root-like system. The bronchi transport air within the lungs to the bronchioles.  
The bronchioles are the end terminuses of the bronchi, and lead to the alveolar sacs. The 
alveolar sacs are tiny balloons that inflate and deflate simultaneously during gas exchange. The 
walls of the alveolar sacs are coated with capillaries, and they facilitate the transfer of CO​2​ out of 
the blood, and O​2​ into the blood.  
 
Mechanics of Breathing 
 
The most important muscle of inspiration is the diaphragm, as seen in Figure 3. It is a 
thin dome-shaped sheet of muscle which is inserted into 
the lower ribs. When it contracts, the abdominal contents 
are forced downwards and forwards, which creates a 
negative pressure within the chest cavity, causing the 
alveolar sacs to inflate. During passive expiration, the 
diaphragm relaxes which causes a positive pressure in the 
chest cavity, and drives the air out of the alveolar sacs. 
Forced expiration, as in coughing or sneezing, utilizes the 
rectus abdominis, internal and external obliques, and 
transversus abdominis muscles to force the diaphragm upwards and create a larger positive 
pressure in the chest cavity, (West, pg. 89-91). 
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Gas Exchange and Respiration 
 
The capillaries of the alveolar sacs are the 
location where gas exchange takes place. CO​2​ is 
removed from the blood and O​2​ is moved into the 
blood. The movement of gases across the capillary 
walls is called diffusion, and in this case is passive 
diffusion. O​2​ and CO​2​ flow from areas of high 
concentration to low. The rate at which the gases 
diffuse is a function of cross sectional area, wall 
thickness, partial pressures, gas solubility, and the gas constant, as explained in Figure 4, (West, 
pg. 22). 
The movement of O​2​ and CO​2​ into and out of the blood is essential for the process of 
cellular respiration. Cellular respiration is the process in which cells break down sugars to create 
energy in the form of Adenosine Triphosphate, (ATP). There are two modes in which cells can 
make ATP. The first is glycolysis, which is the splitting of glucose molecules for a low yield of 2 
ATP and it does not require O​2​. This process also produces pyruvate, which is used in the citric 
acid cycle. In the second process, the citric acid cycle, O​2​ is used as an electron acceptor for 
pyruvate, and makes H+ ions which are used to create a chemical gradient across the membranes 
of the mitochondria. When this gradient is released it creates enough energy to make 34 ATP. 
When O​2​ is not present, the cells cannot conduct the citric acid cycle, and must dispose of the 
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pyruvate by other means. During lactic acid fermentation, the pyruvate is fermented, and turned 
into lactic acid, which can then be deposited into the blood as a waste product.  
 
The Nervous System and Respiratory Controls 
 
The sympathetic and parasympathetic nervous systems govern the body’s reaction to the 
environment. The sympathetic nervous system prepares the body for intense physical activity, 
and is also known as the fight or flight reaction. The sympathetic nervous system stimulates 
several bodily systems, as seen in figure 5. The 
key factor that effects the lungs is the release of 
epinephrine into the blood from the adrenal 
glands. This triggers the beta 1 receptors within 
the heart, causing the heart to beat faster. 
Additionally, the epinephrine triggers the beta 2 
receptors within the bronchioles, causing them 
to dilate in order to keep up with the increased 
demand for O​2​, which is the result of the faster 
heart beat. The parasympathetic nervous system prepares the body for rest and recovery. It 
effects several bodily features as seen in figure 5, including the constriction of the bronchioles. 
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Chapter 1 Asthma 
 
I. Background 
 
Asthma is a chronic inflammatory disorder of the airways. The word asthma is derived 
from the ancient Greek word for “panting”, which highlights the key feature of this disorder. 
Patients who suffer from asthma will undergo episodes, known as “asthma attacks”, which are 
characterized by labored, rapid breathing. Asthma is classified as an air trapping disorder, and 
during these asthma attacks, a patient will struggle to remove air from their lungs. Asthma 
prevalence has increased dramatically over the past 35 years and has become a significant public 
health concern due to the pervasiveness of the disorder and the environmental factors that 
contribute to it, (Broaddus, pg. 1168). 
Chronic asthma is characterized by inflammation of the airway walls, with abnormal 
accumulation of eosinophils, lymphocytes, mast cells, macrophages, dendritic cells, and 
myofibroblasts. Inflammatory mediators and proteins secreted by these cells contribute to lasting 
changes to airway epithelial tissue. These changes result in goblet cell metaplasia and 
subepithelial fibrosis. Due to these changes, an asthmatic’s airway epithelial tissue stores more 
mucus, which can cause obstructions in the form of mucus plugs, and constricts the path to the 
bronchioles and alveolar sacs, (Broaddus, pg. 1176) An asthmatic reaction is a severe 
constriction of the bronchioles, but the reason for this constriction is debated.  
The traditional line of thinking is that the reason an asthmatic’s bronchioles will constrict 
is due to an oversensitivity to mild irritants, (Broaddus, pg. 1169). However, the alternate view is 
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that an asthmatic is less capable of filtering these irritants before they enter the bronchioles due 
to defects in airway epithelial tissue, (Holgate et al. 2009). The airway epithelial tissue is the 
mucus lined coating of the inner airways, and is responsible for trapping both physical and 
chemical irritants before they can enter the bronchioles. Despite the source of the inflammation 
being disputed, it is widely agreed that inflammation and constriction of the bronchioles causes 
the symptoms of asthma. 
Asthmatic airway inflammation begins with an inhaled allergen being processed by 
antigen presenting cells such as dendritic cells or macrophages. These cells present the antigen to 
T cells for secretion of cytokines. The type of cytokine produced will determine the magnitude of 
the inflammatory response, and in asthmatic individuals, inhaled environmental triggers will 
cause the production of Th2 cytokines, rather than Th1 which produce mild inflammatory 
reactions. The presence of Th2 cytokines triggers the production of eosinophils, mast cells, and 
B cells, (Broaddus, pg. 1178). 
 
II. Symptoms and Risk factors 
 
The symptoms of asthma include coughing, wheezing, shortness of breath, difficulty 
breathing, and chest tightness, (Broaddus pg. 1168). These symptoms are a result of 
inflammation in the bronchioles tubes. This inflammation significantly constricts the path from 
the alveoli and requires the individual to work much harder to deflate their lungs. Furthermore, 
during an asthma attack, a patient may become panicked, increasing their heart rate. Increased 
heart rate and decreased air passage frequently leads the patient to become light headed. In some 
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cases this can cause the patient to become unconscious, and can even lead to death if untreated. 
Because of this, asthma is widely recognized as a major cause of disability, medical expense, and 
preventable death, (Broaddus, pg. 1168). 
Chronic asthma creates lasting changes to the structure and function of the airways. 
Frequent damage to airway epithelial tissue, (caused by coughing and wheezing episodes), leads 
to a threefold increase in the amount of mucin stored in the airways, which can cause further 
issues of airway obstruction. Furthermore, the structure of mucus changes in an asthmatic’s 
lungs. Gel-forming mucins become highly expressed, leading to a thicker consistency. This 
thicker mucus is the leading cause of fatal asthma via asphyxiation. This is due to mucus clots 
that become lodged in an airway, also known as mucus plugging, (Broaddus, pg. 1176-1177).  
Individuals with asthma are more prone to environmental factors than non-asthmatics. 
Due to chronic inflammation and damage accrued to the epithelial tissues of the lungs during 
coughing fits, an asthmatic is more susceptible to viral infections. Viruses such as the Human 
Rhinovirus (HRV) are known to worsen an asthmatic’s condition, particularly in the autumn and 
winter months, (Holgate et al. 2009). Other environmental factors will exacerbate the symptoms, 
to include second hand smoke, air pollutants, dust mites, and pet ownership, (Broaddus, pg. 
1170). These environmental factors may cause asthma attacks and increase the frequency of 
attacks. Lifestyle choices can have an effect on the severity of asthma symptoms. These choices 
can include smoking, high intake of salt, and obesity, (Broaddus, pg. 1170). Additionally, 
exercise can cause or exacerbate an asthma attack, and for some, is the most frequent cause of 
attacks. These cases are known as exercise-induced asthma. Furthermore, asthma can be allergy 
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induced, where inflammation, coughing and sneezing, or other symptoms of an allergic reaction 
can trigger an asthma attack. 
Asthma is classified in four general categories based on the frequency and severity of 
symptoms, mild intermittent, mild persistent, moderate persistent, and severe persistent. Mild 
persistent involves mild symptoms up to two days a week and two nights a month, while mild 
persistent is more than twice a week, but not more than once per day. Moderate persistent 
involves daily symptoms and multiple instances at nighttime, and severe persistent is multiple 
occurrences daily and frequently at night, (Asthma, 2016). 
 
III. Detection 
 
There are several methods used to diagnose asthma. One type is lung function testing, 
which is the most simple test, as it involves blowing several breaths into a tube. It measures the 
volume produced and the speed with which air leaves the lungs. A score is assigned based on this 
data, and from the score it can be estimated how constricted the bronchioles are and how likely it 
is that the patient has asthma, (​Asthma and Lung Function Tests, n.d.)​.  
The other diagnostic tools include challenges and tests that screen for the subtle 
differences between a normal lung and that of an asthmatic. One such test is the nitric oxide test, 
which analyzes levels of nitric oxide present in a patient’s breath. Higher levels of nitric oxide 
indicates airway inflammation, a sign of asthma. X-ray scans and CT scans of the lungs and 
nasal cavities can also be used to identify structural abnormalities or infections that are causing 
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breathing issues. Analysis of cough saliva can be used, as patients with asthma will have higher 
concentrations of white blood cells in their saliva, (Asthma, 2016).  
There are also a series of provocative tests that aim to trigger a mild asthmatic reaction. 
One such test is the methacholine test, which requires the patient to inhale a small amount of 
methacholine, a chemical known to trigger asthma. Another form is allergy testing, in which 
allergens are introduced via skin or blood in order to trigger a reaction. Additionally, there are 
provocative tests for exercise and cold, in which a doctor will measure lung function before and 
after vigorous exercise or after several breaths of cold air, (Asthma, 2016). 
 
IV. Treatment 
 
A. Medications 
 
There are two types of pharmacological treatment, short term relievers, and long term 
relievers. Short term relievers are beta​2​ adrenergic agonists and are best delivered by aerosol, 
which maximizes delivery to the airway and minimizes systemic absorption. These beta​2​ agonists 
block beta​2​ receptors in the lungs, reducing the body’s parasympathetic reaction of constricting 
airways. Ipratropium bromide is a fast acting bronchodilator, that relaxes the smooth muscle 
walls of the lungs and submucosal glands by blocking the actions of acetylcholine released from 
the motor branches of the vagus nerve. Ipratropium is delivered via aerosol, usually through the 
use of a rescue inhaler. Ipratropium action peaks within 30 minutes, and its effects last for 4-6 
hours, (Broaddus, pg. 1195). A newer beta​2​ agonist is tiotropium, and it functions using the same 
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mechanisms as Ipratropium, but with the advantage of a 24 hour duration. Additionally, it does 
not inhibit M-2 receptor-mediated inhibition of acetylcholine release from parasympathetic nerve 
endings, (Broaddus, pg. 1195).  
Long term controllers are typically inhaled corticosteroids, that inhibit the production of 
pro-inflammatory cytokines. They also may stimulate the production of anti-inflammatory 
proteins to reduce and prevent inflammation. These are typically delivered in a rescue inhaler, 
but can also be delivered orally on a daily basis to prevent flare ups. Also available are long 
acting beta​2​ agonists such as salmeterol and formoterol, which provide bronchodilation over 
longer periods of time, (Broaddus, pg. 1194). 
Because many asthmatics also suffer from other allergies which create symptoms such as 
sneezing, itchy nose, clear mucus, and nasal congestion, leukotriene modifiers may be used as a 
treatment option. This is not typically the first mode of treating asthma, but it provides an 
effective solution for some. Leukotrienes are the inflammatory chemical the body produces when 
it comes in contact with allergens or irritants, and the subsequently trigger inflammation of the 
bronchioles of an asthmatic during an attack. A leukotriene blocker is a daily ingested 
medication that prevents leukotrienes from activating and causing airway inflammation, and is 
typically used as a treatment option for exercise-induced asthma. In comparison to inhaled 
corticosteroids, however, leukotriene blockers were found to be less effective in clinical trials, 
(Leukotriene Modifiers and Allergies, n.d.). 
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B. Immunotherapy 
 
For some patients with severe allergy-induced asthma that is not controlled by rescue 
inhalers, immunotherapy is a treatment option. Immunotherapy is a reconditioning of an immune 
system that is sensitive to certain allergens. Patients with allergies in addition to asthma may 
choose immunotherapy to prevent the attacks caused by their allergies.  
Allergy shots are one form of immunotherapy, and are usually administered once a week 
for a couple months, and then once a month for 3-5 years. They contain doses of the allergen and 
increase in dosage over time. The result is an eventual buildup of tolerance to the allergen. For 
patients whose asthma attacks are triggered by an allergic reaction, this can reduce the frequency 
of the attacks, and eliminate some environmental triggers, (Allergy Shots, n.d.). 
Omalizumab is another treatment option, and is an injected medication, administered 
every 2-4 weeks, (Asthma, 2016). Omalizumab is a monoclonal anti-immunoglobulin antibody, 
and it prevents allergic reactions by influencing the immune system to create 
anti-immunoglobulins that bind pathogens and preventing them from entering the system and 
causing an allergic reaction. This treatment option has shown to significantly reduce asthma 
exacerbations as a result of allergic reactions, (Willsie, 2006). 
 
C. Other Treatments 
 
For cases that medication and other treatment options do not effectively control a 
patient’s asthma, bronchial thermoplasty may be an option. This procedure is not widely 
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available, and is not suitable for every case. It heats the inner airways using the thermal energy 
from radio frequencies to reduce the mass of the smooth muscle tissue within the lungs, 
(Laxmanan et al, 2015). This thinning of the interior bronchiole walls significantly reduces the 
symptoms of an asthma attack by reducing the amount the airway constricts. While the 
mechanisms of this treatment are not well understood, it is emerging as a viable treatment 
method for some cases of asthma.  
 
D. Lifestyle Changes 
 
Aside from proper medication and treatment, there are various lifestyle adjustments that 
can be made by a person with asthma to reduce the frequency and severity of their attacks. 
Avoiding triggers can play a huge role in a patient’s quality of life. For patients whose asthma is 
triggered by pet dander or dust mites and mold, cleanliness can have a large impact. Cleaning or 
removing carpeting, cleaning areas such as the kitchen and bathrooms, and frequently replacing 
bedding can reduce the amount of airborne irritants. Additionally, the use of air conditioners 
around the house can improve air quality and prevent attacks from occurring, (Asthma, 2016). 
For some patients, air humidity and temperature can cause asthma attacks. Using humidifiers to 
maintain proper humidity and wearing a face mask outside when it is cold can help prevent 
attacks. 
Personal health also has an impact on the symptoms of asthma. Regular exercise has 
shown to reduce the frequency and severity of asthma attacks by increasing the strength of the 
respiratory system. Maintaining a healthy weight also affects the symptoms of asthma by 
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reducing the heart rate and therefore reducing the oxygen demand the lungs must fulfill. 
Additionally, patients can use breathing exercises to strengthen their lungs and reduce the 
amount of medication necessary to control their asthma, (Asthma, 2016). 
 
V. Epidemiology 
 
A. Worldwide prevalence 
 
The International Study of Asthma and Allergies in Childhood examined the prevalence 
of asthma in over 56 countries worldwide in the 1990s, and determined that asthma mortality had 
increased tenfold in the previous three decades. 
Over that time period asthma related hospitalizations 
increased by over 200% in children, and 50% in 
adults. It also found that asthma’s prevalence grew 
exponentially among many european countries, 
(Broaddus, pg. 1170).  Further research and 
surveying in the past two decades has shown, (figure 
6.1), that rates of asthma are continuing to rise, 
especially in developed countries.  
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B. Genetics 
 
There are genetic risk factors that affect the prevalence of asthma. Genome studies have 
isolated 18 genomic regions and over 100 genes that are associated with allergies and asthma, in 
particular, certain areas of the long arms of chromosomes 2, 5, 6, 12 and 13. Specifically, one 
gene, ORMDL3, has been highly correlated with asthma. Mutations in this gene were determined 
to be a cause for the development of childhood asthma, (Subbarao, 2009). 
 
C. Prenatal risk factors 
 
There are several prenatal factors that can influence the development of early childhood 
asthma. Prenatal smoking has consistently been linked with asthma, as well as food allergies and 
a number of other health issues. Diet and nutrition can play a role in the development of 
respiratory disorders. Prenatal consumption of omega-3 fatty acids and high levels of vitamin E 
have both been correlated with a lower risk of development of wheeze before age 6. 
Additionally, prenatal use of antibiotics can have a negative impact on a child’s health, as there 
is a high correlation between antibiotic use and early development of wheeze, (Subbarao, 2009). 
 
D. Childhood risk factors 
 
There are many environmental and social factors that can contribute to early childhood 
development of asthma. In fact, many studies point to the idea that environmental factors are the 
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most critical in the development of asthma. There are mixed results as to the effects of 
breastfeeding, as some studies have seen a correlation between breastfeeding and asthma 
development, while others have shown the opposite, that breastfeeding is correlated with lower 
rates of asthma. However, a meta analysis of these studies has led to the conclusion that 
exclusively breastfeeding for 3 months leads to reduced rates of asthma in children between the 
ages of 2 and 5. Additionally, postnatal exposure to tobacco smoke is consistently associated 
with early childhood development of asthma, as well as the exacerbation of asthma symptoms, 
(Subbarao, 2009). 
An emerging theory on the environmental and cultural causes of asthma is the “hygiene 
hypothesis”. This theory states that the rise in asthma prevalence is an unintended consequence 
of the success of domestic hygiene in reducing infection rates in early childhood, (Broaddus, pg. 
1172). This theory was first formulated through an analysis of rates of asthma in East and West 
Germany during the cold war. It was found that despite higher rates of pollution and overall 
poorer air quality, rates of asthma were lower in East Germany. This phenomenon stemmed 
research into how cultural trends affect the prevalence of asthma. The findings showed that 
western cultural trends were highly correlated with childhood development of asthma, 
(Broaddus, pg. 1172).  
One particular cultural trend is family size, and exposure to other children. Eastern 
cultures tend to have larger families, and are generally more communal. While germs and disease 
spread more easily in this setting, it leads to an higher tolerance of microbes and bacteria, and as 
such, rates of asthma are significantly lower in more “eastern” cultures. On a similar note, the 
tendency to over prescribe antibiotics has not only led to the propagation of new strains of 
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bacteria that are resistant to these antibiotics, but it has also shown a correlation to asthma 
prevalence. Another western cultural trend is living alongside pets. While it has been found that 
children exposed to farm animals have lower rates of asthma overall, children exposed to house 
pets, and especially cats, are more susceptible to asthma. This is largely due to the increased 
presence of dust mites and pet dander, (Broaddus, pg. 1172). 
 
E. Adult onset asthma 
 
Asthma in adults is typically a continuation of childhood asthma or a relapse of childhood 
asthma, but occasionally an adult with no history of asthma will experience symptoms known as 
adult onset asthma. A typical cause of adult onset asthma is a person’s occupational 
environment. Airborne irritants that lead to airway inflammation in a normal respiratory system 
can lead to the development of asthma in some individuals. Occupations that have a higher rate 
of adult onset asthma include painters, hairdressers, domestic and commercial cleaners, 
healthcare professionals, and bakers, among others. Smoking tobacco or marijuana can also lead 
to adult onset asthma as well as more serious respiratory issues, (Subbarao, 2009). 
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Chapter 2 Chronic Obstructive Pulmonary Disease  
 
I. Introduction 
 
Chronic Obstructive Pulmonary Disease, (COPD), is a heterogeneous collection of 
conditions characterized by persistent expiratory airflow limitation, (Broaddus, pg. 1116). It can 
be the result of several etiologies, but the most 
common cigarette smoke. COPD is 
non-reversible, in contrast with asthma, which is 
a reversible air trapping disorder. COPD is 
typically a combination of diseases, asthma, 
chronic bronchitis, and emphysema, as seen in 
figure 2.1. Individuals in subsets 6 and 7 have 
partially reversible COPD. Most patients that 
require medical care for their disease fall into subsets 5 and 8, (Broaddus, pg 1116). 
Chronic Bronchitis is the presence of a productive cough for 3 months during each of two 
successive years. Patients with other sources of chronic cough such as mycobacterium 
tuberculosis, carcinoma of the lung, bronchiectasis, cystic fibrosis, and chronic congestive heart 
failure have been excluded from chronic bronchitis. It is characterized by a chronic cough that is 
unrelated to other respiratory issues, (Broaddus, pg. 1116). Emphysema is a abnormal permanent 
enlargement of the air spaces in the respiratory bronchioles accompanied by destruction of their 
walls and without obvious fibrosis. This destruction is nonuniformity in the appearance of the 
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acinus and its components within the alveolar walls, and reduces the alveoli ability to facilitate 
gas diffusion, (Broaddus, pg. 1117). 
A triad of overinflation, oligemia, and bullae are the major contributing factors to the 
symptoms and associated diseases of COPD. Overinflation of the lungs is the phenomenon 
where air becomes trapped in the alveolar sacs because of obstructions in the bronchioles. 
Oligemia is a decrease in volume of blood plasma, and is a result of decreased amounts of salt 
and ions in the blood. Bullae are blister like sacs of fluids, frequently caused by burns to the 
epithelial tissue resulting from inhaling smoke. These bullae further obstruct the path to and from 
the alveoli. These three conditions cause the symptoms of COPD by obstructing the path to the 
alveoli and reducing the body’s ability to exchange gases. Trapped air becomes more acidic as 
CO​2​ builds, which reduces the chemical gradient necessary for gas exchange, and reduced blood 
volume reduces the solubility of gases in the blood, (Broaddus, pg. 1118). 
 
II. Signs and Symptoms 
 
The most obvious signs of COPD include coughing, breathlessness, and wheezing. 
Typically a patient with COPD will exhibit course crackling during air intake. These symptoms 
will worsen and cause other issues as the disease progresses. There are four stages of the disease. 
Patients with stage 1 COPD (mild) experience coughing, slight airflow limitations, and 
sometimes an increase in mucus production, but generally no other symptoms. Stage 2 
(moderate) patients will experience decreased airflow, breathlessness, coughing, wheezing, and 
sputum production. Stage 3 (severe) patients will see an increase in these symptoms, particularly 
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breathlessness and exhaustion, and likely will require intermittent hospitalization. Stage 4 (end 
stage) patients experience an increase of breathlessness and exhaustion. COPD flare ups for stage 
4 patients can be potentially life threatening, and require hospitalization, (​Is COPD a Progressive 
Disease, 2017).  
Sputum production is altered in individuals with COPD. In reaction to tissue damage 
cause by emphysema or accumulation of bullae in the bronchioles and alveoli, the lungs will 
overproduce mucus. When coughed up, sputum will be purulent, which is composed of white 
blood cells, cellular debris, and serous fluids, and is typically yellow or green. Additionally, 
Hemoptysis can occur, which is blood in the sputum, and is a result of epithelial tears, most 
frequently from coughing fits, (Broaddus, pg. 1120) 
Damage caused by emphysema reduces the body’s ability to transfer gas into and out of 
the blood. This leads to conditions such as hypoxemia, which is an abnormally low concentration 
of O​2​ in the blood, or hypercapnia, an abnormally high concentration of CO​2​ in the blood. These 
conditions are problematic for cellular respiration as cells need O​2​ to process glucose. 
Furthermore, they need a chemical gradient in order to deposit waste CO​2​ into the blood, which 
is more difficult with already high levels of CO​2​, (Broaddus, pg. 1120).  
Low levels of O​2​ and high levels of CO​2​ in the blood can lead to metabolic acidosis, 
which is the decrease in blood pH, and is more common in late stage COPD. It is frequently the 
result of increased amounts of lactic acid fermentation in the cells from anaerobic respiration. 
The waste product, lactic acid is deposited in the blood, leading to an overall lower pH, 
(​Metabolic Acidosis, 2017). Many patients with COPD develop pulmonary artery hypertension, 
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which is high blood pressure of the pulmonary artery. It is caused by reductions in capillary 
compliance and blockages, caused by emphysema damage, (Broaddus, pg. 1119). 
COPD also leaves patients highly susceptible to other illnesses. COPD is considered to be 
an important predisposing condition for pneumonia. Furthermore, symptoms of pneumonia can 
be difficult to distinguish from acute exacerbations of COPD, which increases the risk of 
mortality, (Broaddus, pg. 1121). Additionally, due to hypertension, patients with COPD are at 
significant risk of developing cardiac disease and other heart related issues, mainly due to 
systemic inflammation, (Broaddus, pg. 1123). 
 
III. Detection and Diagnosis 
 
A) Spirometry and disease tracking 
 
The most typical diagnosis of COPD is conducted with spirometry, which is the 
measurement of the ratio of forced expiratory volume in one second (FEV​1​) over forced vital 
capacity (FVC). The results of this test are applied to the GOLD staging system, which is used to 
track the progression of the disease. Stage 1 is categorized by an FEV​1​ of 80% or higher while 
stage 2 individuals will have and FEV​1​ of 50-79%. Stage 3 is 30-49%, and stage 4 is less than 
30% FEV​1 ​, (Johns et al. 2014). Periodically, individuals with COPD will have spirometry tests 
conducted to re-assess the progress of their disease.  
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B) Arterial blood gas analysis 
 
Arterial blood gas analysis (ABG) provide estimates of the acuteness and severity of 
disease exacerbation. As the disease worsens, a patient’s hypoxemia worsens. During acute 
exacerbations, gas exchange and lung mechanisms worsen, and the blood becomes more acidic 
because of increased levels of CO​2​. ABG measures the acidity of the blood, and a pH of 7.3 or 
lower is considered to be a sign of acute respiratory compromise, (​Chronic Obstructive 
Pulmonary Disease (COPD) Workup, 2017). 
 
C) Chest radiographs 
 
Chest radiographs can be used to reveal the presence of pulmonary artery hypertension in 
patients with emphysema. From front and lateral scans, physicians will be able to note several 
features, to include flattening of the diaphragm, increased retrosternal airspace, a long narrow 
heart shadow, rapidly tapering vascular shadows and hyperlucency of the lungs. Patients with 
COPD tend to show increased bronchovascular markings and cardiomegaly, (Barker, 2006). 
 
D) High resolution CT scans 
 
CT scans may be used to determine if surgical intervention is necessary, but can also be 
used to diagnose various forms of COPD, as well as determining causes of the symptoms of the 
 Frederick 21 
disease. CT scans have a greater sensitivity than standard radiographs, and as so have a higher 
specificity for diagnosing emphysema, (Imaging, n.d.). 
 
E) Other tests 
 
Other tests can be conducted to determine the extent of the disease, as well as many other 
factors. Hematocrit tests assess the ratio of red blood cells to total blood volume, and a ratio of 
.52 for men or .47 for women indicates that the patient should be screened for hypoxemia. Serum 
potassium tests measure levels of potassium in the blood, which is an indicator of metabolic rates 
and can be used to diagnose metabolic acidosis. Sputum evaluations are used to show a 
transformation from mucoid, which is typical of stable COPD, to purulent, which indicates high 
levels of white blood cells. Pulse oximetry is used to determine O​2​ levels in the blood, which is 
indicative of the progression of the disease. Electrocardiography is used to rule out the heart as 
the cause of respiratory issues, as it will rule out cardiac ischemia, which can be caused by 
hypoxia. Additionally, two dimensional echocardiography may be used to screen for pulmonary 
hypertension, and right sided heart catheterization is used to confirm pulmonary hypertension 
and gauge the patient’s response to vasodilators, (​Chronic Obstructive Pulmonary Disease 
(COPD), 2017). 
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IV. Treatment 
 
COPD is a progressive disease, and currently there is no cure. However, there are several 
treatment methods that can be used to manage the disease at its various stages. The number one 
therapeutic intervention is smoking cessation. There are also a series of medications and 
therapies available to treat this disease. 
 
A) Medications 
 
Current symptom-based therapies are primarily directed at reducing airway smooth 
muscle tone or at reducing inflammation, (Broaddus, pg. 1143). In cases where bronchospasms 
are present, bronchodilators can be used to improve airflow. However, even in cases that 
bronchospasms are not present, it is still recommended that bronchodilators are used. Patients 
with COPD will see modest to large improvements in airflow after use, and as such patients with 
COPD are always given a clinical trial of bronchodilators. Patients are typically prescribed long 
acting beta​2​ agonists such as salmeterol and formoterol, which provide bronchodilation over 
longer periods of time, and are administered daily orally, (Broaddus, pg. 1144). A patient with 
COPD typically will be prescribed a rescue inhaler with fast acting beta​2​ agonists and 
glucocorticoids. The fast acting agonists reopen airways, and corticosteroids reduce the 
inflammation, (Broaddus, pg. 1145). 
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B) Pulmonary Rehabilitation 
 
Pulmonary rehabilitation attempts to return patients to their highest possible lung 
functional capacity. The benefits include increased independence and quality of life, decreased 
hospitalization, and improved exercise capacity. Exercise conditioning is the single most 
important aspect of rehabilitation. Improving cardiovascular endurance helps to maximize a 
patient’s lung capacity at various stages of the disease. Additionally, muscle strengthening using 
light weights, specifically upper extremity exercises, has shown to be beneficial as it reduces the 
effort needed to perform day to day tasks, (Broaddus, pg. 1149). 
Respiratory muscle training is controversial, but some methods have proved to be 
beneficial. The most reliable method is a pressure-threshold breathing device, that involves 
producing an inspiratory pressure of at least 30% of the patients maximum inspiratory pressure. 
The goal is to spend 30 minutes a day using this device. Additional exercises include pursed lip 
breathing, which involves standing in a bent position with arms outstretched against a wall. This 
exercise decreases air trapping and improves diaphragm function, but also has benefits in 
controlling resting dyspnea, anxiety, and panic attacks, (Broaddus, pg. 1149). 
 
C) Surgical intervention 
 
There are few surgical options to treat COPD, but the most successful is single lung 
transplantation. This is preferable over double lung transplantation, which requires cardiac 
bypass, and has a higher rate of complications. Furthermore, one donor may supply two patients 
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with a new lung. Lung transplant still remains one of the most difficult transplants in comparison 
to other solid organs such as the heart or kidneys, and has a high rate of complication and 
rejection. Another surgical procedure is surgery for bullous lung disease, which involves the 
surgical removal of giant bullae. This procedure may significantly improve a patient’s lung 
capacity depending on size and location of the bullae, as well as capacity of non-bullous lung 
tissue. This procedure is not used in most cases of COPD.  
 
V. Epidemiology 
 
A) Worldwide prevalence 
 
The prevalence of COPD varies from country to country in adults age 40 and older. This 
is because of a wide range of environmental and cultural factors. An Australian study placed 
COPD prevalence at 7.5% overall, but with greater rates for those aged over 75, for which the 
rate was 29.2%. A more recent study conducted worldwide among smokers estimated that for 
those age 30-69, rates of COPD were 54% for males and 24% for females, (Johns et al. 2014). In 
America, COPD was the third leading cause of death in 2014, affecting almost 15.7 million 
Americans, primarily those aged 65-74, (​Chronic Obstructive Pulmonary Disease (COPD), 
2017). 
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B) Gender and socioeconomic status 
 
Most population studies have reported that men have a higher prevalence of respiratory 
symptoms than women, even when the studies are controlled for smokers. However, recent data 
suggests that female may be at an increased risk for developing COPD, with more women in the 
United States dying from the disease than men. Furthermore, rates of morbidity and mortality are 
inversely proportional to socioeconomic status, measured in income and level of education. 
Generally, COPD is more prevalent among “blue collar” workers than “white collar”, (Broaddus, 
pg. 1126) 
 
C) Exposure to toxic fumes and gases 
 
Cigarette smoking is the most important 
exposure risk factor for COPD. Smoking affects 
rates of COPD in a dose dependant manner, as 
seen in figure 2.2. Tobacco smoking accounts 
for 80% to 90% of risk of developing COPD in 
the United States. Other environmental factors 
affect the diseases prevalence. Occupational 
exposure to chemicals and pollutants are associated with accelerated loss of lung function. 
Farming or working in dusty occupations increases the risk of developing chronic bronchitis 
two-threefold. In the developing world, exposure to smoke generated from the burning of 
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biomass fuels are a comparable risk of developing COPD as is smoking cigarettes, (Broaddus pg. 
1126-1127). 
 
D) Non-environmentally acquired COPD 
 
The “Dutch hypothesis”, is that an “asthmatic constitution”, influences the development 
of chronic airflow limitations. This hypothesis states - in some cases - that chronic asthma can 
lead to fixed airflow obstruction. The “British hypothesis” states that innate development of 
COPD is a result of mucus hypersecretion that causes a more rapid decline of lung function with 
age. Additionally, the deficiency of the homozygous alpha​1​-protease inhibitor is a significant risk 
factor for the development of COPD, (Broaddus, pg. 1126-1127). In any case, the presence of 
respiratory issues of any sort in early life have shown to have a great impact on later life 
prevalence of COPD.  
 
E) Perinatal and childhood effects 
 
Maternal smoking has shown to lead to childhood respiratory illnesses and low birth 
weight. Both low birth weight and childhood respiratory infections and diseases are positively 
correlated with the development of COPD in later life, (Broaddus, pg. 1127). 
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F) early onset COPD from marijuana abuse 
 
Use of marijuana has been linked to symptoms of COPD and is now included as a 
differential diagnosis in bullous emphysema. Marijuana abuse has become a growing trend 
worldwide in the past decade, and while there have been few population studies as to these 
trends and the resulting effects on respiratory health, multiple case studies have been conducted 
that demonstrate the damaging effects of frequent use. On average, smoking marijuana involves 
a two-thirds larger puff volume, a one-third greater depth of inhalation, and a four-times longer 
breath holding time than that of cigarette smoking. For these reasons, it has been estimated that 
three to four “joints” of marijuana has an equivalent effect on the lungs as smoking an average of 
24 cigarettes a day, (Golwala, 2012). 
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Chapter 3 Pneumonia 
 
I. Introduction 
 
Pneumonia is an infection in the lower respiratory tract, (LRT), which entails the trachea, 
bronchioles and alveoli. It causes inflammation of the alveoli, and a buildup of pus and fluids in 
the alveolar sacs, which leads to the signs and symptoms of pneumonia. This fluid buildup can 
become solid, and can be fatal if untreated. Pneumonia is curable, with many treatment options 
for its various types. Nonetheless, pneumonia is a common cause of death worldwide, and as 
such requires proper treatment and early detection to prevent mortality.  
The microorganisms that infect the LRT may reach the lungs by four routes, direct 
extension from the mediastinum or subphrenic space, hematogenous seeding from an 
extrapulmonary focus, inhalation of microorganisms, and aspiration of oropharyngeal contents. 
The latter two routes are the most common modes of infection, (Broaddus, pg. 921). Typically 
inhaled particles expand upon entering the trachea due to humidity, and as such do not pass 
through the terminal bronchioles. Only fine particles (less than 5 m in size) are able to enter theμ  
alveoli. Because of this only small bacteria are able to enter the alveoli and potentially cause an 
infection. Additionally, a penetrating bacteria must also evade the host defences. However, as is 
the case with aspiration pneumonia, larger bacteria may penetrate the lungs when a large particle 
becomes lodged in the bronchioles during the daytime, and eventually moves to the alveoli 
during sleep when the airway walls relax and expand, (Broaddus, pg. 921). 
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Whether or not a microorganism can take hold and cause an infection is a result of the 
three major components of lung defence, mechanical defences such as cough and mucus 
entrapment, humoral immune factors in respiratory secretions such as lysozyme or 
immunoglobulins, and cellular components of immunity such as alveolar macrophages. Complex 
interactions between the virulence and quantity of inhaled or aspirated microorganisms that 
contaminate the LRT determine whether pneumonia develops, (Broaddus, pg. 921). 
 
II. Signs and Symptoms 
 
Typical symptoms of an LRT include coughing, chest pain, shortness of breath, 
wheezing, sore throat, and other symptoms of infection. Due to an increased amount of fluids in 
the alveolar sacs, the patient will cough to try to rid their lungs of the fluid. Sore throat usually 
develops as a result of the cough. Furthermore, the buildup of fluids combined with 
inflammation of the alveoli and bronchioles reduces the lungs ability to intake air and exchange 
gas, leading to shortness of breath. Reduced gas exchange can lead to other symptoms such as 
fatigue and blue lips or fingers. Chest pain is due in part to inflammation of the alveoli and 
bronchioles, but also is a result of inflammation of the pleura, also known as pleuritis, 
(Broaddus, pg. 941). 
Additionally, a patient will experience symptoms of infection that are a result of the body 
fighting the infection. These include nausea, chills, fever, swollen lymph nodes, and abnormal 
sputum production. Swollen lymph nodes are an indication that the nodes are filtering lymph 
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fluid, and producing large amounts of lymphocytes in order to kill microorganisms. As dead 
white blood cells and microorganisms accumulate, sputum will become purulent. 
 
III. Detection and Diagnosis 
 
When an LRT is suspected, a laboratory evaluation is conducted to determine factors 
such as blood cell counts, serum glucose and electrolyte measurements, and pulse oximetry or 
arterial blood gas assays, (Broaddus, pg. 926). Additionally, a radiographic evaluation is done to 
establish the presence of pneumonia. Finding the etiology of the infection is key in determining 
the treatment method. There are several microbiologic evaluation tools used for this task. 
Microscopic examination of sputum is the easiest and most available method to 
determine the etiology of a case of pneumonia. Approximately 40% of pneumonia cases can be 
positively diagnosed using this method. Typically fluorescent antibodies are used to evaluate the 
sputum sample and determine the type of microorganism that is causing the infection, (Broaddus, 
pg. 928).​ ​Blood and pleural cultures can also be used to definitively determine the etiology, 
although blood cultures are only able to pinpoint the bacterial source in roughly 20% of cases, 
(Broaddus, pg. 929). Often the most practical means to establish a microbiological diagnosis is 
serologic techniques. This is typically used when the pathogen cannot be readily cultured as is 
the case in M. pneumoniae, C. pneumoniae, and L. pneumophila, (Broaddus, pg. 929). 
Because of issues with contamination of expirated sputum samples, invasive diagnostic 
techniques may also be used to determine the etiology of pneumonia. Bronchoscopic samples 
can be taken during a bronchoscopic procedure and then analyzed with the same techniques used 
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in sputum evaluations. Transthoracic lung aspiration obtains specimens suitable for 
microbiological and cytologic examinations directly from lung parenchyma, but it tends to be 
more successful in diagnosing malignant pulmonary lesions than infectious diseases. Lung 
biopsy is another option, but it is rarely used because less invasive methods are usually able to 
diagnose the etiology of pneumonia, (Broaddus, pg. 931).  
 
IV. Treatment 
 
Because pneumonia is a bacterial infection of the lungs, once the strain is determined, the 
appropriate antibiotic must be administered. So long as the antibiotic is administered early 
enough and no complications occur, the patient will recover. Antibiotics are typically a fungi 
such as penicillin, but other lipid forms and antimicrobial peptides are available. Antibiotics 
selectively target specific characteristics of different bacteria, such as the presence of a cell wall, 
and kill the bacterial cells. Different etiologies of pneumonia require different antibiotic 
treatments. Table 3.1 summarizes the agents used to target the many etiologies of pneumonia.  
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 Table 3.1​ agents for specific therapy of selected respiratory pathogens, 
(Broaddus, pg. 937) 
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V. Epidemiology 
 
A) Worldwide prevalence 
 
Globally, pneumonia is a serious health concern. Despite advances in antimicrobial 
therapies, diagnosis and prevention, pneumonia remains the leading cause of death from 
infectious disease worldwide, (Cilloniz et. al, 2016). In 2014, the eighth cause of mortality in the 
United States was Influenza and pneumonia combined, and it is estimated that there are 4 million 
cases of community acquired pneumonia, (CAP), annually in the United States. The mortality of 
CAP in hospitalized patients is 14%, but this number jumps to 20-50% in patients requiring 
intensive care, (Broaddus, pg. 920). Pneumonia is also the single largest infectious cause of death 
in children worldwide; in 2015, 920,136 children under the age of 5 perished from the disease, 
which accounts for 15% of childhood mortality, (Cilloniz et. al, 2016).  
The most common cause of CAP is streptococcus pneumoniae, (pneumococcus). 
Pneumococcus was recognized by the World Health Organization in 2014 as one of the 9 
bacteria of international concern. However a wide range of pathogens are responsible for 
nosocomial pneumonia, (Cilloniz et. al, 2016). 
 
B) Community acquired pneumonia 
 
Age, social habits, comorbidities, geographic setting, time of year, recent travel, and 
occupational or other unusual exposures change the risk of different respiratory tract infections, 
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(Broaddus, pg. 926). Table 3.2 summarizes the prevalence of different forms of pneumonia 
based on underlying disease or setting. 
 
Table 3.2 ​Organisms prevalent in bacterial pneumonia according to disease or setting, 
(Broaddus, pg. 926). 
Alcoholism 
Streptococcus pneumoniae, Haemophilus influenzae, Anaerobes, Klebsiella pneumoniae 
Risk of Aspiration 
Anaerobes, Staphylococcus aureus, Gram-negative bacilli 
Chronic Obstructive Pulmonary Disease 
S. pneumoniae, Moraxella catarrhalis, H. influenzae 
Intravenous Drug Use 
S. aureus 
Neutropenia 
Pseudomonas aeruginosa, Enteric gram-negative bacilli, S. aureus 
Cell-Mediated Immunodeficiency 
Legionella, Nocardia 
Human Immunodeficiency Virus (HIV) 
S. pneumoniae, H. influenzae, S. aureus, Rhodococcus equi 
Cystic Fibrosis 
P. aeruginosa, S. aureus, Burkholderia cepacia 
Airway Obstruction 
S. pneumoniae, H. influenzae, S. aureus, Anaerobes 
Pulmonary Alveolar Proteinosis 
Nocardia 
 
As mentioned in previous chapters, existing respiratory disorders frequently lead to 
further respiratory infections and diseases. When the respiratory system is weakened by one 
disease and another associated disease takes hold and causes mortality, it is referred to as a 
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comorbidity. Due to the severity of pneumonia, and the prevalence of the disease, pneumonia is a 
common comorbidity of several respiratory and non-respiratory disease, to include asthma, 
COPD, cystic fibrosis, HIV, diabetes, and several others, (Segal et. al, 2018). 
Table 3.2 displays this phenomenon 
and the associated bacteria that a patient will 
be more likely to contract. Figure 3.1 
displays the overall prevalence of each strain 
of bacteria. Pneumococcus is widely 
accepted as the most common causative 
microorganism in Community Acquired 
Pneumonia, (CAP), (Cilloniz et. al, 2016). 
In CAP, roughly 6% of the cases involve Multidrug-Resistant pathogens, (MDR). 
Community-Acquired Methicillin-Resistant S. Aureus, (CA-MRSA), is the most common MDR 
and has become a growing health concern due to its resistance to current treatments. Due to this, 
early detection and diagnosis is key in reducing mortality rates of this pathogen, (Cilloniz et. al, 
2016). 
 
C) Nosocomial pneumonia 
 
Nosocomial pneumonia is pneumonia not contracted through interactions with people. 
The most common type of this pneumonia, Hospital Acquired Pneumonia, (HAP), is defined as 
pneumonia ​not incubating at the time of hospital admission and occurring 48 h or more after 
 Frederick 36 
admission, ​(Cilloniz et. al, 2016). Another type 
of nosocomial pneumonia is 
Ventilator-Associated Pneumonia, (VAP), 
which ​is defined as a pneumonia occurring >48 
h after endotracheal intubation, ​(Cilloniz et. al, 
2016). HAP is the second most frequent 
nosocomial infection, but is considered to be the 
leading cause of death in nosocomial infections. VAP accounts for 70-80% of HAP cases 
acquired in intensive care units, (Cilloniz et. al, 2016). As was the case with instances of CAP, 
the origin of nosocomial pneumonia can be traced back to one of many bacteria strains, as seen 
in Figure 3.2.  
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 Chapter 4 emerging concerns in respiratory health 
 
I. Introduction 
 
This chapter examines emerging concerns in respiratory health in America as a result of 
changes in public opinion and popular culture. Additionally this chapter examines ever present 
respiratory health concerns associated with weapons of mass destruction.  
 
II. Cannabis COPD and Lung Cancer  
 
Cases of lung injury due to smoking marijuana have been a growing trend in America. 
The legal use of cannabis for medical purposes began in 1996 with California’s approval of 
proposition 215. Since then the majority of states in the U.S. have made the medical use of 
cannabis legal for the treatment of several diseases, for example Cancer, HIV, Glaucoma, 
seizures, migraines, and arthritis. In 2012, marijuana became legal for recreational use in both 
Colorado and Washington, and has since become legal in a hand full of other states. While there 
are few population studies on the effects to respiratory health, many case studies have emerged 
of individuals with a history of frequent cannabis use with severe cases of lung injury.  
Smoking marijuana has been linked to rates of lung cancer. One population study 
determined that smoking one joint per day for a year, (1 joint-yr), led to a 8% increase in risk of 
developing lung cancer. This rate is comparable to that of smoking one pack of cigarettes (20 
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cigarettes) for one year, at rate of 7%. The risk of developing lung cancer has a linear association 
to joint-yrs, with a patient who smokes 3-4 joints per day for a year to have a 24-32% risk of 
developing lung cancer, (Tanoue, 2010). 
One study examined a patient with severe bullous emphysema. The patient in this case 
study had a history of a few years of marijuana abuse, which entailed 3-4 joints of marijuana per 
day for 8 years. The severity of the patient’s bullous emphysema was determined to be the cause 
of the patient’s marijuana abuse, as all other potential causes were eliminated. From this study, it 
was estimated that 3-4 joints per day gives as many symptoms as smoking 24 cigarettes daily. 
The reason that cannabis is more potent in terms of lung health is that ​on average, smoking 
marijuana involves a two thirds larger puff volume, a one third greater depth of inhalation, and a 
four times longer breath holding time than that of cigarette smoking​, (Golwala, 2012).  
From this estimation, it can be expected that individuals that smoke cannabis at a rate of 
3-4 joints daily will have the same risk of developing other respiratory disorders as that of an 
individual who smokes over 20 cigarettes per day. For example, a young individual who smokes 
cannabis at these rates has a 30% risk of developing COPD from ages 20-29, and a 60% risk of 
developing COPD between ages 60-70. The phenomenons of early onset COPD as a result of 
smoking marijuana and marijuana induced lung cancer are under-studied and will likely become 
a significant public health concern in the timeframe of 20-30 years after the legalization of 
recreational marijuana.  
 
 
 
 Frederick 39 
 III. Electronic Cigarette Associated Illness 
 
Popcorn lung, formally known as 
hypersensitivity pneumonitis, is ​an 
inflammatory syndrome of the lung caused 
by repetitive inhalation of antigenic agents in 
a susceptible host. There are three antigens 
that cause this allergic reaction, microbes, 
animal proteins, and low molecular weight 
chemicals, (Hypersensitivity pneumonitis, 
2017). Popcorn Lung was first recognized in popcorn factories, where workers would contract 
symptoms similar to COPD. These symptoms were due to scarring of the alveolar and bronchiole 
walls which causes obstruction of the airways. It was eventually discovered that this condition 
was caused by airborne diacetyl, the chemical used to create a buttery flavor. Subsequently, 
popcorn companies removed diacetyl from their products. Hypersensitivity pneumonitis is once 
again becoming prevalent however, due to the popularity of e-cigarettes, also known as vaping.  
Vaping is widely considered to be a “safe” alternative to smoking, as it delivers nicotine 
to the user via water vapor. Vaping does not present the negative health effects associated with 
smoking or the use of chewing tobacco, but there are still negative health implications associated 
with vaping. Aside from nicotine poisoning, which accounts for about 44% of vaping related 
injuries, there are several systemic injuries that can be acquired from e-cigarette use. 
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Cardiovascular and gastrointestinal effects are among these, but the most prevalent are 
respiratory illnesses, (Hua, 2016). Popcorn lung is an associated illness of vaping, as flavor 
mixes have diacetyl, which causes inflammation and scarring of the airway walls.  
Other issues with vaping include the efficiency of the vaporizing system. Several case 
reports have led to the discovery that poor efficiency of vaporizing systems can lead to 
overheating of the vape mix which can have negative respiratory impacts. One such impact is the 
overheating of propylene glycol, an agent used to extract cannabis oil for vape mix. While 
propylene glycol is classified as safe for consumption by the FDA, it has the potential to 
transform into carbonyls such as formaldehyde, which is carcinogenic and a respiratory irritant, 
(He et. al, 2017).  
 
IV. Inhaled Insulin and Asthma 
 
Diabetes is a widespread disease that effects the body’s ability to produce insulin, and 
leads to abnormal metabolism of carbohydrates and elevated blood glucose levels. It can be 
caused by a genetic deficiency that impairs the body’s ability to produce insulin, but the disease 
can also develop over time as a result of the body resisting insulin, or not being able to produce 
enough insulin. Current treatments include diet and exercise, as well as insulin therapy. One 
form is inhaled insulin, which delivers a powdered form of insulin directly to the blood via the 
lungs. This method acts faster than other subcutaneous methods, and is minimally invasive. 
There are however slight concerns to respiratory health associated with inhaled insulin.  
 Frederick 41 
A person with asthma in addition to diabetes is at risk of exacerbating their asthma by 
using inhaled insulin. Furthermore, during an asthma exacerbation, a person with asthma will not 
be able to pass as much insulin to their blood via inhalation, and as a result will need to inhale 
more insulin, (Mastrandrea, 2006). 
 
V. WMDs 
 
Chemical warfare or weapons of mass destruction pose an ever-present risk for 
respiratory illness. Major conflicts such as World War I left many with illnesses associated with 
chemical warfare. Chemical warfare typically is airborne and delivers a chemical agent to the 
body, the most common being vesicants (blister or 
mustard agents), nerve agents, and blood agents. 
Vesicants pose the greatest risk to the respiratory 
system. Vesicants, such as mustard gas, cause 
severe burns to the skin, eyes, and respiratory tract 
as seen in Figure 4.2. They result in large yellow 
blisters that cover affected areas, and can lead to 
immediate formation of bullae within the lung tissue, which will prevent the person from passing 
air. Even with proper treatment readily available, contact with mustard gas frequently leads to 
death. Survivors of mustard gas inhalation are at an increased risk of developing lung cancer and 
chronic bronchitis. Immediate decontamination and treatment are essential to minimize the 
effects, (Gosden et. al, 2006). 
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Chemical warfare was banned in 1925 by the Chemical Weapons Convention, and made 
it illegal to use or possess chemical weapons. Nonetheless, chemical warfare and the associated 
illnesses have still been an issue. One such occasion was the Iraq-Iran war of 1980-1988, which 
saw the use of mustard gas among other chemical weapons. Out of the 34,000 Iranians affected 
by mustard exposure, the most prevalent health issue after 13-20 years were respiratory issues in 
the form of lesions, at 42.5%, (Khateri, 2003). Chemical warfare remains an important public 
health concern, and requires a state of constant readiness to treat victims of these attacks, 
respiratory and otherwise.  
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